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ISOLATION OFMALASSEZIA  SPECIES FROM CLINICALLY 
DIAGNOSED CASES OF PITYRIASIS VERSICOLOR AND 
SEBORRHEIC DERMATITIS AND DETERMINATION OF 
ANTIFUNGAL SUSCEPTIBILITY OF THE ISOLATES 
ABSTRACT 
INTRODUCTION: 
 Ever since its inception, the genus Malassezia has been a topic of 
intense basic research in various aspects including taxonomy, physiology, 
epidemiology, metabolomics and immunology.  The etiopathologic links 
between these yeasts and many superficial and systemic infections have been 
unveiled by clinical research.  Pityriaisvericolor (PV) and seborrheic dermatitis 
(SD) are superficial skin infections that have an established causal association 
with Malassezia species. 
STUDY BACKGROUND AND OBJECTIVES:   
            The  objective  of  this study is to make use of the biochemical and 
physiologic differences among the various species of Malassezia to gain an 
insight into the epidemiology and the risk factor associations of these yeasts 
with pityriasisversicolor and seborrheic dermatitis in this part of our country, 
known for its hot and humid climate, which favours the growth of these yeasts 
and also to determine the antifungal susceptibility of the isolates to the  
commonly used azoles and amphotericin B. 
MATERIALS AND METHODS: 
 This study was done at Madras Medical College, Chennai for a period of 
one year involving 100 clinically diagnosed cases of  Malassezia infections, of 
whom 73 had pityriasisversicolor and 27 had seborrheic dermatitis.  Skin 
scrapings from the lesional sites were collected using strict aseptic precautions 
and processed bystandard microbiological methods.  Christensen’s urease 
medium with the addition of Tween compounds was used for antifungal 
susceptibility testing of the Malassezia isolates to fluconazole, itraconazole, 
ketoconazole, voriconazole and amphotericin B.   
RESULTS: 
 Pityriasisversicolor commonly occurred in the 20 – 29 years age group 
(42.5%) and seborrheic dermatitis in the 40 -49 years age group (44.5%).  
Males were affected more commonly than females with both PV (72.6% males) 
and SD (74% males).  Majority of the PV patients presented with lesions on the 
back (50.7%).  Face and scalp (63%) were the common sites involved in SD.  
Majority of  PV patients had hypopigmented lesions (63.1%).  The overall 
culture positivity rate was 70%, the yield being higher with PV lesions.  
Among the PV cases, 92.6% of the hyperpigmented lesions were culture 
positive.  M. globosa was the most common species isolated in PV and SD.  
Low MIC ranges and low MIC50  values of  < 1 µg/ml were noted with 
amphotericin B, ketoconazole and itraconazole for most of the Malassezia 
species. 
CONCLUSION: 
 Culture is an important step in the diagnosis of Malasseziainfections due 
to interspecies variability exhibited by Malassezia species in the etiological 
role in different geographical areas and differences in their susceptibility 
patterns to antifungal agents.  Culture and antifungal susceptibility testing in 
the management of Malassezia infections will lead to a better targeted 
approach, reducing the cosmetic concerns, chronicity and recurrences 
associated with these infections.   
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INTRODUCTION 
 
 Fungi are widely distributed in environment, but hardly 400 species are 
recognized as primary human and animal pathogens, of which less than 100 are 
encountered in routine clinical practice.8  Most of the fungi which were considered 
non-pathogenic or mere laboratory contaminants are now being encountered as 
significant emerging agents of fungal diseases. Depending on the site of primary 
involvement, fungal infections may be classified as Superficial, Cutaneous, 
Subcutaneous and Systemic mycoses.8 
 
 Infection limited to the outermost layers of the skin and its appendages 
with little or no tissue reaction is said to be superficial mycoses, which is by far 
the commonest type of fungal involvement.8  Pityriasis versicolor and seborrheic 
dermatitis are such superficial mycoses caused by fungi belonging to the genus 
Malassezia. Malassezia species are part of the indigenous human flora found in 
the stratum corneum of the back, chest, scalp and face, which are rich in 
sebaceous glands.9 Though considered as commensal yeasts of human and animal 
skin, these fungi have been implicated in inducing or aggravating the following 
conditions: 
 
 superficial skin infections like pityriasis versicolor, seborrheic 
dermatitis, atopic dermatitis, folliculitis, papillomatosis, onychomycosis 
and external ear infections,8 
 pneumonia,8 
 peritonitis8, 28  and also  
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 fungemia in patients receiving parenteral lipid supplementation, 
especially preterm neonates.8, 28, 89 
 
 The net outcome of the fungus – host  relationship determines the 
establishment of the disease process.11  This is particularly significant in the 
present era of advanced medical facilities, where the number of 
immunocompromised hosts is on the rise.  
 
 The recognition of the significance of Malassezia had been progressing 
slowly due to the difficulty in the isolation of these lipophilic yeasts in the routine 
laboratory setting.  In the recent years, research on this genus has been expedited 
by the introduction of molecular methods, which have contributed to the 
understanding of its epidemiology, pathogenesis and management by robust 
interventional strategies, given that these yeasts are not only involved in 
superficial infections, but also disseminated infections and that different species 
exhibit varying sensitivity patterns18  to the antifungal agents. To date, there are 14 
species of Malassezia that have been isolated from human and animal skin.29 
 
 Pityriasis versicolor and seborrheic dermatitis, the two most common 
manifestations of Malassezia, though not alarming infections, are conditions 
known for their chronicity and recurrence and also for raising cosmetic concerns 
in those affected by these conditions.8,11 
 
 This part of our country is known for its hot and humid climate that favours 
the growth of Malassezia yeasts, and hence an understanding of the distribution of 
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these yeasts and the dominant species prevalent, will serve to complement 
previous studies conducted in India and elsewhere in determining the varying 
trends in distribution that may exist in different geographical locations.             
 
 This study purports to analyze the clinicoepidemiological profile of 
patients clinically diagnosed to have pityriasis versicolor and seborrheic 
dermatitis by making use of the physiological and biochemical differences among 
the various species of Malassezia.  Also, an understanding of the locally prevalent 
antifungal susceptibility patterns of these yeasts would serve as a guide in the 
choice of appropriate antifungal agents, as Malassezia species exhibit variable 
susceptibility patterns. Though molecular methods are considered accurate and 
less time consuming for the confirmation of Malassezia species, simple methods 
based on evaluation of morphological, physiological and biochemical 
characteristics are more economical and adoptable by almost any laboratory and 
are hence employed in this study. 
 
 
 
 
 
 
AIMS & OBJECTIVES 
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AIMS AND OBJECTIVES 
 
 To identify and isolate Malassezia yeasts from patients clinically 
diagnosed with Pityriasis versicolor. 
 
 To identify and isolate Malassezia yeasts from patients clinically 
diagnosed with   Seborrheic dermatitis. 
 
 To speciate the isolated Malassezia yeasts from pityriasis versicolor 
and seborrheic dermatitis using  physiological and biochemical tests. 
 
 To analyze the clinical patterns of  pityriasis versicolor and seborrheic 
dermatitis infections with respect to epidemiological attributes and 
other risk factors. 
 
 To determine the antifungal susceptibility of the Malassezia isolates 
obtained from pityriasis versicolor and seborrheic dermatitis lesions. 
  
 
 
 
 
 
 
REVIEW OF 
LITERATURE 
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REVIEW OF LITERATURE 
 
HISTORY 
 Malassezia was first identified as the causative agent of pityriasis 
versicolor by  Eichstedt in 1846 and by Sluyter in 1847.1  In 1953, the yeast was 
named Microsporum furfur by Robin, as it was closely related to the 
dermatophyte Microsporum audouinii.  Baillon recognized the error and created 
the genus Malassezia.11  The description of Malassezia was given in 1874 by the 
French scientist Louis Charles Malassez, who identified  budding ‘spores’ in the 
epidermis of patients with seborrheic dermatitis. 1 
 
 Spherical and oval budding cells were observed by Bizzozero, who named 
them Saccharomyces sphaericus and Saccharomyces ovalis, respectively.  Baillon 
in 1889, used the designation Malassezia furfur in honour of Malassez.8  
Sabouraud in 1904, proposed the genus Pityrosporum to describe budding yeast 
cells without hyphal elements.  Castellani and Chalmers in 1913 were the first to 
isolate the lipophilic oval budding cells from normal skin and patients with 
seborrheic dermatitis and to coin the term Pityrosporum ovale.8 
 
 Previously, the mycelial phase of the organism was designated Malassezia 
and the yeast phase was called Pityropsorum orbiculare (round cells with budding 
from narrow neck) or Pityrosporum ovale (oval yeast cells with budding from 
wide neck).  On the basis of the distinct cell surface antigens, Cunningham and 
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colleagues in 1990 defined the  serovars A, B and C. These serovars are now 
identified as M. sympodialis, M. globosa and M. restricta, respectively.44 
 
 The lipophilic nature of the genus Malassezia was discovered in 1939 by 
Rhoda Benham.11 Von Abbe in 1964 described the Dixon medium for the 
isolation of Malassezia yeasts which was subsequently modified for better yield.28 
 
TAXONOMY 
 Taxonomically, the genus Malassezia is classified under the Family 
Cryptococcaceae of form Class Blastomycetes in the order Malasseziales in 
Phylum Basidiomycota, based on its morphologocial and biochemical 
characteristics like  
 
 laminar ultrastructure of cell wall 
 ability to hydrolyse urea  
 positive staining with Diazonium Blue B (DBB)8 
 
 The taxonomy of the genus Malassezia has been controversial since 1889, 
when Baillon first created it on identifying Malassezia furfur.   Malassezia furfur, 
the first species to be identified has been known by various other names including 
Pityrosporum orbiculare, Microsporum furfur, Sporotrichum furfur, Oidium 
furfur, Malassezia tropica, Malassezia macfadyeni. 11 
 
 The genus has been revised based on morphology, physiology, cellular 
characteristics, temperature requirements, biochemical reactions, dependence on 
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long chain fatty acids, guanine and cytosine content of cellular DNA and 
ribosomal RNA sequences to include fourteen species.2,3,4,6 
 
 The fourteen species are enumerated below along with the name of the 
scientist who first reported the species and the year of reporting: 
 
Malasseziaspp. Authors who first reported Year 
M. furfur Baillon 1889 
M.pachydermatis Dodge 1925 
M. sympodialis Simmons and Gueho 1990 
M. globosa Midgley, Gueho and Guillot 1996 
M. obtusa Midgley, Guillot and Gueho 1996 
M.restricta Gueho, Guillot and Midgley 1996 
M. slooffiae Guillot, Midgley and Gueho 1996 
M. dermatis Sugita, Takashima, Nishikawa, Shinoda 2002 
M. japonica 
 
Sugita, Takashima, Kodama, Tsuboi and 
Nishikawa 2003 
M.yamatoensis Sugita, Tajima, Takashima et al 2004 
M. nana Hirai, Kano, Makimura, Yamaguchi, Hasegawa 2004 
M. caprae Cabanes and Boekhout 2007 
M. equi Cabanes and Boekhout 2007 
M. cuniculi F. J. Cabanes et al 2011 
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ECOLOGY: 
 Malassezia species are mesophilic and have an absolute requirement of 
lipids for growth and survival.  Hence, they are known to inhabit the skin of only 
warm-blooded animals.11M. pachydermatis is known to cause canine ear 
infections.  M. furfur and M. obtusa have also been isolated form otits externa in 
dogs and M. sympodialis from cats.  Many lipophilic species of Malassezia  have 
also been isolated from pigs, monkeys, rhinoceros, bears and birds. 11 
 
 Crespo Erchiga et al by their studies on healthy human skin have 
concluded  M. sympodialis to be the most common species isolated from normal 
human skin, especially the trunk.64  It can be found alone or in combination with 
M. globosa in the skin of face.64  Midgley has reported a higher incidence of M. 
globosa in the human  scalp.2 
 
 Japanese authors and others have obtained varied results probably due to 
differences in the sampling techniques, culture media used and also due to 
geographic and ethnic factors.4, 5 
 
 Sugita et al found M. furfur, M. sympodialis, M. globosaandM. restrciato 
be the four common species in the scalp and nape of healthy individuals, using a 
nested polymerase chain reaction technique.5 
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PATHOGENICITY OF MALASSEZIA: 
Pityriasis versicolor (PV): 
 PV is the most common condition associated with Malassezia fungi.  It is a 
chronic, recurrent superficial skin infection involving the stratum corneum, 
resulting in fine scaly hypopigmented to hyperpigmented lesions of various 
shades.10, 28   It most commonly involves upper trunk, neck, face and upper arms.  
Recent studies by culture identification and characterization of physiological and 
morphological features have suggested M. globosa to be the most common 
species associated with PV.63, 68 
 
Seborrheic dermatitis (SD): 
 SD is a chronic inflammatory dermatitis, where erythematous skin is 
covered with greasy, white, furfuraceous flakes.  In its mildest form involving the 
scalp, it is called dandruff.8  The areas commonly affected are scalp, face, chest, 
back, nasolabial folds and flexures.28 
 
 M. globosa, M. sympodialis and M. restricta are the common species 
isolated from SD lesions.8 SD is recognized as an early indicator of AIDS in 
immunocompromised individuals.27 
 
Atopic dermatitis (AD): 
 Atopic dermatitis is a chronic dermatosis that is intensely pruritic.  It 
occurs in individuals with a genetic predisposition to atopy.  Erythema, papules 
and pruritis are common in neck, face and scalp of the affected.  A vicious itch- 
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scratch-itch cycle occurs.  Itching results in secondary excoriations and 
lichenification of the skin. 8 
 
 Malassezia yeasts and fungal componenets from Cryptococcus diffluens 
and Cryptococcus liquefaciens may play a role in the pathogenesis of AD by 
acting as allergens.  Yellowish desquamation of the scalp in the neonates, known 
as ‘cradle cap’ is a presentation of atopic dermatitis.8 
 
Folliculitits: 
 Earlier known as Pityrosporum folliculitis, Malassezia folliculitis is a 
chronic inflammatory condition characterized by acneform, pruritic eruptions in 
the form of pustules and erythematous papules.  The areas commonly involved are 
upper back, anterior chest, arms and shoulders. 8 
 
 The yeast is present in the ostium and central and deep segments of hair 
follicle. This condition commonly affects young women. Acne vulgaris and 
staphylococcal folliculitis are among the conditions included in the differential 
diagnosis of  Malassezia folliculitis.28 
 
Systemic infections: 
 Systemic infections like pneumonia, peritonitis, fungemia and other 
disseminated infections due to Malassezia have been reported in 
immunocompromised individuals and neonates with cardiovascular diseases and 
those receiving lipid hyperalimentation.9 
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 The portal of entry has been found to be intravenous catheters, the usual 
manifestation being lipid deposition in the pulmonary arteries.  M. furfur has been 
recovered from the yeast-containing cutaneous pustules and positive blood 
cultures in these conditions.51, 72 
 
Other conditions associated with Malassezia:  
 Malassezia may play a role in onychomycosis, confluent reticulated 
papillomatosis of Gougerot and Carteaud and obstructive dacryocystitis.11  
 
 M. pachydermatis, previously thought to be a zoophilic organism, has been 
linked to a series of neonatal infections in a nursery, that spread from a healthcare 
worker whose pet dog was colonized with the fungus.89 
 
 A recent study has also linked neonatal cephalic pustulosis, also known as 
neonatal acne to M. sympodialis.62Malassezia species have also been isolated 
from cases of onychomycosis and hyperproliferative lesions of psoriasis.28, 55 
 
 Recently, based on a metabolomics research, a hypothesis has been 
proposed, which links radiation induced basal cell carcinoma to aryl hydrocarbon 
receptors synthesized by Malassezia yeasts.97 
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                                         PITYRIASIS VERSICOLOR 
 
SYNONYMS: 
 Tinea versicolor, dermatomycosis furfuracea, chromophytosis, tinea flava, 
liver spots are the various names given to pityriasis versicolor.11 
 
INTRODUCTION: 
 PV is a scaling, superficial, pigmentary dermatoses that occurs when 
Malassezia overgrowth extends to adjacent skin from the follicles.   The name 
‘tinea versicolor’, by which it was known earlier is a misnomer and ‘tinea’ is 
reserved for dermatophytic infections.8 
 
 The term ‘pityriasis versicolor’ is particularly apt in that the color of the 
lesion varies according to the skin colour of the patient, sun exposure and severity 
of the disease (pityriasis is derived from a Greek word ‘ptyra’ meaning abnormal 
proliferation and versicolor is derived from a Latin word meaning many 
colours).11 
 
 In the past, PV was considered as a mark of beauty in some rural areas of 
Sri Lanka and hence treatment was not sought.  In local terms it was referred to as 
‘Gomora’, meaning ‘tears of liquid gold’.8 
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CLINICAL PRESENTATION: 
PV may present in various forms as follows:  
 Flat, fine scaly, hypopigmented or hyperpigmented  0.5 – 1 cm macules on 
the trunk, that may coalesce to form larger plaques or gyrating areas of 
intermittent scaling of  different colors and shades in the skin of neck, 
arms, chest and back.11 
 Inflammatory pustular lesions that may be scaling or non-scaling 29 
 Lesions affecting face, extremities and flexural areas that is commonly 
seen in immunocompromised individuals.29 
 
 Lesions on dark or tanned skin tend to be hypopigmented (achromic PV).  
In white skinned individuals, the lesions are hyperpigmented (chromic PV), 
appearing darker than the surrounding skin.29 
 
 Both hypopigmented and hyperpigmented lesions may occur in the same 
individual in different locations.10  Various factors influence the colour variation, 
including the thickness of the horny layer, severity of infection and the metabolic 
products released by the organism.30 
 
 Early lesions are perifollicular in origin.The lesions may be aymptomatic 
or pruritic.  Irritation or inflammatory response is rare, but some may present with 
reddening and pruritus especially after sun exposure.10  The main complaint is 
cosmetic, the affected areas failing to tan normally.11 
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 The scaly nature, unique to PV can be demonstrated by light scratching 
with a scalpel or microscopic slide or fingernail, the so called coup d’ angle of 
Besnier or scratch sign or chip sign or fingernail sign.11 This sign is absent in 
early lesions and in previously treated patients.31, 32 
 
PATHOGENESIS:   
 As the causative fungus is universally present as normal flora of skin, it 
may be considered as an opportunist that elicits disease under special situations.11  
Lee et al, by scanning electron microscopic studies showed that a morphological 
change from the saprophytic yeast form to filamentous mycelial form is important 
in the pathogenesis of  Malassezia infections.33 A reduction in the turnover of 
squamous cells by endogenous or exogenous corticosteroids may lead to 
development of PV.  
 
 Malassezia are dependant on exogenous lipids, especially 12 to 14 carbon 
fatty acids for their growth.  Human and animal skin, rich in free fatty acids, serve 
as media for their growth and survival.  Metabolism of skin surface lipids by 
lipoxygenase enzymes of Malassezia, yields fatty acids that are toxic to the 
melanocytes. 13 
 
 Many theories have been postulated to explain the pigment alterations 
associated with PV: 
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1. Studies by Nazzaro – Porro in 1993 showed that the metabolism of oleic 
and vaccenic acids by Malassezia yielded lipid fractions like C9 to C11 
dicarboxylic acids. One such metabolite is azelaic acid, a dicarboxylic 
acid which competitively inhibits tyrosinase in the melanin synthesis 
pathway leading to smaller and fewer melanosomes and also inhibits the 
mitochondrial enzymes, leading to vacuolation and degeneration of the 
melanocytes, thus resulting in hypopigmentation.34 
 
2. In studies by Allen et al and Charles et al, hyperpigmented lesions were 
found to show an increased turnover rate of stratum corneum, i.e, 8 days 
compared to 15 days for normal areas and also the presence of singly 
distributed, large melanosomes in contrast to multiple – packaged, smaller 
melanosomes in normal areas.11                                
 
3. Mayser and coworkers, by their studies on the metabolism and nutritional 
requirements of Malassezia species in 1998, have concluded the colour 
change of the affected skin in PV to reflect the exclusive property of M. 
furfur to assimilate L- tryptophan as a nitrogen source.15, 16    
 
4. Raabe et al in 2000, have confirmed the pigmentogenesis of  M. furfur, 
based on their observations of non-lipid-dependent M. pachydermatis that 
produces lower pigment. The indole pigment pityriacitrin produced 
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exclusively by M. furfur acts as a UV filter, preventing normal 
tanning.17,84 
 
 
5. Borgers et al, by scanning and transmission electron microscopic studies, 
have confirmed the penetration of Malassezia into the keratinocytes, 
causing degradation of the keratin into an amorphous lipid–like substance, 
that acts as a potential ultraviolet light blocker and results in 
hypopigmentation.35 
 
6. The hyperpigmentation (chromic type of PV) is said to be multifactorial, 
caused by the presence of large number of the causative fungi, increased 
thickness of the keratin layer, increased turnover rate of cells in the 
stratum corneum, increased perivascular infiltration of lymphocytes and 
increased inflammatory responses that stimulate the melanocytes.  
Hyperpimented lesions have been found to contain more hyphae and 
spores than the hypopigmented ones.36 
 
PATHOLOGY: 
 The budding yeast cells and hyphae are confined to the outermost layers of 
stratum corneum.  If very large numbers are present, they may be seen cemented 
together as a continuous layer, replacing the outer cells of the stratum corneum.  
The organism may be seen as a mass near the hair follicle and extending into the 
follicular opening.  The yeast cells are 2 - 8 µ in diameter and hyphae about 3 – 4 
µ in width.  11 
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IMMUNOLOGY: 
 Normal epithelial turnover in the skin precludes infection.  In chronic 
cases, antibodies are detectable.  Specific IgG, Ig A and IgM antibodies are 
induced by M. furfur.Malassezia may induce psoriasis-like lesions by activating 
the alternate complement pathway.12 
 
EPIDEMIOLOGY: 
 Pityriasis versicolor is worldwide in distribution.  Hot and humid 
environmental conditions favour the infections and so it is more common in 
tropical and subtropical climates than in temperate ones, where the infections may 
occur only in summer.25 
 
 In tropical countries, the incidence of PV is about 35 – 40%, while in the 
temperate climates it may be as low as 1 – 4 %.  The true prevalence however, is 
very difficult to estimate, as the affected individuals seek medical attention only 
for cosmetic reasons.21 
 
 PV occurs commonly in adolescents and young adults, in whom sebum 
production is higher than in other age groups.11 A severe form of disease occurring 
in infants as a depigmenting diaper rash (achromia parasitica) may be seen in 
some climates.10 
 
 The amount of colonizing yeasts in different age groups seems to correlate 
with variations in sebum secretion that are age-dependent.10   
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AGE  GROUP 
 
PERCENTAGE OF SKIN COLONISATION WITH 
MALASSEZIA YEASTS 
0 – 10 years 5  – 15 % 
11 – 20 years 56 – 90 % 
 
 Predisposing factors for the infection include heredity, glucocorticoid 
medications, chronic infections, ill health, hyperhidrosis, greasy skin and 
exogenous oil application.25 
 
DIFFERENTIAL DIAGNOSIS:        
 Pityriasis rosea, other pigmentary disorders like vitiligo and chloasma, 
erythrasma, secondary syphilis and pinta11  have to be differentiated from 
pityriasis versicolor.   
 
SEBORRHEIC DERMATITIS (SD) 
SYNONYM:    Seborrheic eczema 
INTRODUCTION: 
 Seborrheic dermatitis is a chronic papulosquamous disorder, affecting 3 – 5 
% of the general population, predominantly children and young adults.  
Seborrhoea is derived from the Latin word ‘sebum’ meaning ‘grease’and the 
Greek word ‘rhoea’ meaning ‘flow’.8 
 
 Cradle cap in neonates can also occur as a part of a generalized disorder 
called Leiner disease, associated with diarrhea and failure to thrive.22 
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CLINICAL FEATURES: 
 SD manifests as erythematous, pruritic scaly lesions in the scalp and face, 
particularly, forehead (especially glabella), external auditory canal, nasolabial 
folds, retroauricular area, eyebrows and moustache and also the presternal area.8,25 
 
 The individual lesions may be dull-red, sharply marginated papules or 
macules on a greasy, erythematous base with extensive scaling and crusting with 
variable pruritis.9 
 
 In patients with advanced Acquired Immuno Deficiency Syndrome (AIDS) 
with low CD4 counts, seborrheic dermatitis is often severe and difficult to treat.9 
 
RISK FACTORS FOR SD: 
 Immunosuppression, prematurity, Human Immunodeficiency Virus (HIV) 
infection, Parkinson’s disease, dark skinned races, alcoholism, emotional stress, 
endocrine disorders associated with obesity, facial Psoralen Ultraviolet A therapy 
(PUVA), all predispose to seborrheic dermatitis.26  
 
 A higher incidence of SD has also been seen in patients with pityrosporum 
folliculitis and pityriasis versicolor.26 
 
 Drugs that can trigger SD-like eruptions include griseofulvin, cimetidine, 
methyldopa, buspirone, chlorpromazine, phenothiazine, methoxsalen, interferon – 
α, ethionamide, etc.25 
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PATHOGENESIS:   
 Therapeutic studies with the antifungal agent ketoconazole, have suggested 
the causative role of Malassezia in seborrheic dermatitis.23  The observation that 
people with Parkinson’s disease who typically show increased sebum secretion on 
account of dopamine deficiency have a markedly higher incidence of SD, supports 
the role of sebum in the causation of SD.24 
 
 Higher skin surface levels of squalenes and free fatty acids (FFA) have 
been found in patients with SD.   The resident flora of the skin, i.e, 
Propionibacterium acnes and Malassezia have lipase activity, that transforms 
triglycerides to free fatty acids.  The FFA and the reactive oxygen species (ROS) 
thus produced, have antibacterial activity that alters the normal skin flora.  This 
disturbance in flora, lipase activity and ROS may be linked to SD.25 
 
 Recent studies have shown an increased production of aryl hydrocarbon 
receptor (AhR) ligands by Malassezia species isolated from patients with 
seborrheic dermatitis.97  An interplay of the AhR and EGFR (Epidermal Growth 
Factor Receptor) has also been suggested to play a causative role in SD.97 
 
PATHOLOGY: 
 Malassezia may grow in large numbers in and around the hair follicles and 
sebaceous glands.  Histopathologic studies have shown their presence in follicular 
ostia, infundibulum of pilosebacous canal and the surrounding dermis.  The 
follicles are dilated and plugged with keratinous debris.  Parakeratosis  containing 
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sebum and neutrophils are seen at the ostia (called ‘follicular lipping’). 
Inflammatory infiltrates of lymphocytes and neutrophils are seen in follicular 
epithelium.22 
 
 In SD associated with HIV infection, plasma cells and apoptotic 
keratinocytes may also be observed.   These changes contribute to folliculitis and 
seborrheic dermatitis.11 
 
IMMUNOLOGY: 
 Abnormal immune response to normal levels of Malassezia species on the 
skin, resulting in depressed T- helper cell response and lower levels of 
phytohaemagglutinin and concanavalin may be observed.12 
 
 An increase in the number of CD16 and NK -1 cells in seborrheic 
dermatitis have been demonstrated by Faergemann et al87.  A disturbed 
lymphocytic cellular immune response and the resulting elevated IL-10 and 
reduced IL-2 and IFN- γ can lead to complement activation via the direct and 
alternative pathways.25 
 
SD IN HIV AND AIDS:  
 Extensive SD is seen in patients with HIV and AIDS, that is refractory to 
standard therapy.  On histopathological examination, much more necrosis, 
lymphocytosis, focal leukocytosis and parakeratosis are common compared to the 
seronegative controls.  SD usually occurs with CD4 counts of 200 – 500 cells / 
cu.mm as one of the earliest skin manifestations in HIV patients.27 
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EPIDEMIOLOGY: 
 The  incidence of seborrheic dermatitis has been estimated to be 3 – 5 % of 
the general population.  A male predominance is seen in all ages for SD.25  In the 
United States, the reported prevalence of SD is high, reaching 11.6%.25 
 
 A generalized form of seborrheic dermatitis is rarely seen in infants and 
may be linked to immunodeficiencies.22In individuals with Parkinson’s disease 
and those with neutropenia, the incidence and severity of SD have been found to 
be higher.8 
 
 Flare ups are common with seasonal fluctuations in humidity and 
temperature, particularly with low humidity in the winter and early spring.25 
 
 Though a family history of SD has often been reported, it was only recently 
that a mutation in ZNF750 encoding a Zinc finger protein C2H2 had been 
identified, resulting in autosomal dominant seborrhea-like dermatitis.25 
 
DIFFERENTIAL DIAGNOSIS:  
 Acne vulgaris, dermatophytosis, psoriasis, candidiasis, atopic 
dermatitis,acne rosacea, systemic lupus erythematosus, Langerhans cell 
hsitiocytosis are among the conditions that should be differentiated from 
seborrrheic dermatitis.8 
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DIAGNOSIS OF MALASSEZIA INFECTIONS 
 
 The diagnosis of superficial skin infections caused by Malassezia is mainly 
clinical.  Laboratory diagnosis in the form of potassium hydroxide mount can be 
done to differentiate from other similar conditions.25 
 
 Culture is rarely done for diagnostic purposes, but carries importance in 
research and epidemiological settings and for confirmation in case of systemic 
infections.   
 
 Pityriasis vesicolor can be detected by the characteristic fluorescence on 
Wood’s lamp examination.8, 25 
 
WOOD’S LAMP EXAMINATION: 
 Wood’s lamp was invented by Robert Woods, a Baltimore physicist.  It 
was initially used by Margaret and Devez for detection of dermatophyte infections 
of hair.37 
 
 Wood’s lamp consists of a high pressure mercury arc that emits long 
wavelength ultraviolet light and a filter made of 9% nickel oxide and barium 
silicate (called ‘Wood’s filter’), that transmits light of wavelength between 320 – 
400 nm, being opaque to all other wavelengths of light.  Fluorescence of the 
illuminated tissue results when this UV light is absorbed and a visible light of 
longer wavelength is emitted.38  Skin is fluorescent due to its constituents like 
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aromatic amino acids, melanin and its precursors and elastin. Normal skin is very 
faintly fluorescent or not at all.39 
 
Before using a Wood’s lamp, it should be ensured that  
 The light source is at a distance of 4 inches from the object to be 
illuminated 
 The lamp is allowed to warm up for 1 – 2 min 
 The room should be dark and the examiner must get adapted to the dark to 
be able to appreciate the contrast clearly. 
 Topical creams and ointments and other cosmetics should be wiped off 
thoroughly from the area to be visualized in order to avoid false positive 
fluorescence due to petroleum jelly or salicylic acid.40, 41, 42 
 
Advantages of Wood’s lamp: 
 Wood’s lamp is small, inexpensive, easy to handle requiring no expertise. 
It can be used in the outpatient department for instant diagnosis.38 
 
 In the case of pityriasis versicolor, yellowish orange or golden yellow 
fluorescence is produced due to coproporphyrin.24  It is also useful in detecting 
sub-clinical lesions and the extent of skin involvement.43 
 
SPECIMEN COLLECTION: 
 The nature of the specimen to be collected in infections caused by 
Malassezia,depends on the type of involvement.  For superficial skin infections, 
skin scrapings and punch biopsy of the lesional skin may be sampled.  Scrapings 
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or clippings from the involved nail in case of onychomycosis, hair sample in case 
of folliculitis, peritoneal fluid in case of peritonitis, respiratory secretions in case 
of pneumonia, catheter tip and venous blood in case of fungemia are to be 
examined.9, 28, 11, 30 
 
 In superficial skin infections like PV and SD, skin scrapings have proven 
to be simple, minimally invasive and informative samples.   
 
I. Collection of skin scrapings: 
 The skin in the affected area is disinfected with 70% isopropyl alcohol to 
remove surface contaminants.  The area is allowed to dry and scrapings are 
obtained on to a sterile dark paper or an alcohol cleansed, flame-sterilized glass 
slide, from the active edges of the lesion using the blunt end of a no. 15 flame–
sterilized scalpel blade or the edge of a glass slide.8 
 
 The specimens from scalp may best be obtained by scraping with the blunt 
end of the scalpel so that the hair stubs, scales and the contents of the plugged 
follicles are included.8 
 
Alternative methods: 
Alternative methods adopted for specimen collection are the following: 
 
 Scotch tape method: 
A Vinyl Adhesive Tape (also called VAT or scotch tape) can be pressed 
firmly over the affected area of the skin and the scales can be collected for 
preparation of potassium hydroxide mount.  The tape is placed on  a glass 
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slide with a few drops of 10% KOH in the centre .44  This method is 
especially useful when scales are minimal.  The disadvantage of this 
method is that culture cannot be done.  
 
 Contact plate method:  
A culture plate containing suitable agar can be pressed directly on the 
affected skin for culture purpose. The disadvantage of this method is that 
direct KOH examination cannot be done.71 
 
 Wood’s lamp method: 
When the lesional area is indistinct, an initial Wood’s lamp examination to 
delineate the infected area may be done, followed by sampling by any of 
the above mentioned methods.8 
 
DIRECT MICROSCOPY: 
A) Potassium hydroxide (KOH) mount: 
 The scales obtained by scraping or scotch tape method from suspected 
superficial skin lesions are examined with 10 – 20% KOH, which digests the 
keratin and cellular debris and enables visualization of fungal elements.8, 28 
 
Modifications of KOH mount: 
 Dimethyl sulfoxide (DMSO) may be added to the preparation, which 
allows better visualization by acting as a clearing agent.8 
 Methylene blue may be added to delineate fungal elements28 
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 Albert’s stain stains the yeast cells and hyphae purple, delineating them 
from the background of keratinocytes.8 
 Parker Quink’s blue or black ink can be used with KOH to enhance the 
contrast28 
 
B) Calcoflour white stain(CFW): 
 CFW is a water-soluble, non-toxic, colourless fluorescent whitener and 
textile dye that selectively binds to cellulose and chitin of the fungal cell wall.  
When viewed under fluorescent microscope, it fluoresces light blue on exposure 
to UV light (340 –   365 nm).8 
 
 CFW stain is superior to conventional KOH mount in that it provides a 
better differentiation of hyphal elements and collagen fibres. 
 
Appearance in direct microscopy: 
 On direct microscopic examination of the KOH, modified KOH or CFW 
preparation, Malassezia species exhibit the characteristic ‘banana and grapes’ or 
‘spaghetti and meat ball’ appearance, showing clusters of round or oval 2 – 7 µ 
yeast cells and short ( about 20 – 25 µ), stout, septate, sometimes phaeoid 
appearing hyphal elements. 
 
II. Punch biopsy: 
 Punch biopsy of skin obtained from the lesional area may be subjected to 
histopathological examination after staining with Gomorri’s methanamine silver, 
Geimsa, haematoxylin and eosin or periodic acid Schiff stain.28 
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 Presence of yeast cells and hyphal elements may be noted in the stratum 
corneum, which is thickened, compared to normal skin.  The thickening is more 
pronounced in the hyperpigmented type of PV.46 
 
CULTURE: 
 All Malassezia species are lipophilic (with the exception of   
M.pachydermatis), requiring 7 – 10 days for growth on lipid supplemented 
media.11  Nonetheless, culture may be essential to establish the diagnosis in 
Malassezia infections.   
 
Growth requirements: 
 Fatty acids are essential for the in vitro growth of all Malassezia species 
except M. pachydermatis.  Replication of the organism is supported by saturated 
or unsaturated fatty acids of C12 to C24 series.  Conversion of yeasts to mycelial 
form is supported on media containing glycine, glucose, mineral oils, glycerol 
monostearate or Tween 80.14  Glycine has a unique positive effect on the growth 
of M. furfur.11 
 
 Malassezia yeasts grow ideally at a temperature of 30 - 35˚C. 
Temperatures above this range are inhibitory to most species.  Preservation of 
Malassezia species is best done by freezing at -80˚C, as the cultures do not 
survive temperatures of 4 - 8˚C.8 
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CULTURE MEDIA: 
The following media support the growth of Malassezia species: 
1.  Sabouraud Dextrose Agar with an overlay of olive oil8, 28 
2.  Modified Dixon’s agar with 3.6% malt extract, 0.6% peptone, 1% Tween 
40, 2% desiccated ox bile, 0.2% glycerol, 0.2% oleic acid, that provides 
substantial growth of the yeast with distinctive morpholological patterns 
for identification.8, 28 
3. Leeming and Notman medium with whole fat cow’s milk, that has a longer 
shelf-life and a higher recovery rate.8,28 
4. GYP-S agar with peptone, glucose, yeast extract, olive oil, Tween 80, 
glycerol monostearate to provide quicker growth and quantitation of 
colonies.8 
5. A minimal medium with lipid source and L- typtophan to selectively 
induce a diffusible brown pigmentation specific for M. furfur. This medium 
does not support the growth of some strains of M.pachydermatis and 
M.sympodialis.8 
 
 It is recommended that all the above media be supplemented with 
cycloheximide and chloramphenicol, as all Malassezia species are part of 
commensal flora of human and animal skin.28 
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 Modified Dixon’s medium and Leeming and Notman agar are the two most 
widely used media for culture.  The former is preferred over the latter by many 
authors as its dark coloration makes recognition of colonies easier when more 
than one species is isolated and also enables better counting of colonies.28 
 
 All inoculated culture media should ideally be incubated at a temperature 
of 30 - 35˚C (preferably at 32˚C), for a period of 7 – 10 days and examined daily 
for growth.25 
 
COLONY MORPHOLOGY ON MODIFIED DIXON’S AGAR: 
 The morphological features of the colonies of commonly isolated 
Malassezia  species on modified Dixon’s agar are as follows: 
 
Malassezia furfur : 
 M. furfur generates cream coloured, thick, convex, umbonate, 4 – 5 mm 
colonies with a smooth to rough surface.8, 28 
 
Malassezia pachydermatis: 
 M. pachydermatis forms cream coloured, thick, convex colonies with a 
matte surface and brittle texture, making it difficult to emulsify. 8, 28 
 
Malassezia sympodialis: 
 M. sympodialis forms cream to buff coloured, flat, easily emulsifiable 
colonies with a slight central elevation and a smooth shiny surface. 8, 28 
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Malassezia globosa: 
 M. globosa produces 4 mm cream to buff colonies with a rough and deeply 
folded surface and a brittle texture and hence are difficult to emulsify. 8, 28 
 
Malassezia obtusa: 
 M. obtusa is a slow growing species and forms small colonies with a sticky 
texture. 8, 28 
 
Malassezia restricta: 
 M. restricta is slow growing and forms irregular, small, 2 mm sized, cream 
coloured colonies with a hard texture.8, 28 
 
Malassezia slooffiae: 
 M. slooffiae forms 3 mm colonies, with finely folded margins and a brittle 
texture. 8, 28 
 
GRAM STAINING: 
 Gram staining of the colonies of Malassezia species show gram positive 
budding yeast cells, with cellular morphology characterisitic of each species.  
They are as follows: 
 
M. furfur: 
The gram positive yeast cells of M. furfur are morphologically 
heterogeneous, showing globose, cylindrical or oval yeast cells 4 – 5 µ long, with 
some filamentous forms (pseudohyphae without dolipores).28 
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M. pachydermatis: 
 The yeast cells are 2 – 4 µ oval to cylindrical with broad based budding.28 
 
M. sympodialis:  
 The yeast cells are 2- 5 µ ovoid cells, with narrow based sympodial 
budding, giving a ‘clover leaf’ appearance. 28 
 
M. globosa: 
 The yeast cells are spherical, 6 – 8 µ diameter with narrow based buds and 
pseudofilaments. 28   
 
M. obtusa: 
 The yeast cells are among the largest in the genus, being up to 10 µ long 
and with broad based budding. 28 
 
M. restricta: 
 The yeast cells are 2 – 4 µ spherical to oval, with narrow based buds. 28 
 
M. slooffiae: 
 The yeast cells are short cylindrical and never globose or elongated.  Buds 
are broad based.28 
 
BIOCHEMICAL CHARACTERIZATION: 
 Conventional assimilation and fermentation tests employed in the 
speciation of other yeasts cannot be used for these non–fermentative, lipophilic 
species.8, 28  The various tests used to identify Malassezia species are as follows: 
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Urease test: 
 All Malassezia species are capable of producing urease enzyme that 
hydrolyzes urea in the Christensen’s urea agar or broth medium modified by the 
addition of 0.5% Tween 40, turning the colour of the medium pink.8, 73 
 
Catalase test: 
 20 – 30% hydrogen peroxide can be used to detect the catalase activity of 
Malassezia species.  M. restricta is the only species that is catalase negative.67, 68 
 
Esculin hydrolysis test: 
 Beta glucosidase enzyme present in some species of Malassezia hydrolyzes 
esculin in esculin agar medium, releasing esculetin that reacts with iron in the 
medium to cause blackening of the agar.68, 77 
 
 This enzyme activity is positive with M. sympodialis, M. obtusa, 
M.cuniculi and M. caprae, weakly positive or absent with M. furfur, and variable 
with M. pachydermatis.28 
 
Growth at 42˚C:  
 M. sympodialis, M. furfur, M. pachydermatis, M. dermatis, M.japonica, 
M.slooffiae and M. cuniculi are the species capable of growth at 42˚C.28, 77 
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Tween assimilaton test: 
 The ability of the individual Malassezia species to utilize different Tween 
compounds, i.e, 10% Tween 20, 0.5% Tween 40, 0.5% Tween 60 and 0.1% 
Tween 80 as the sole source of lipid is tested by tween assimilation test.28 
 
 Tween compounds are water – soluble, nonionic surfactants, which are 
polymers of ethylene oxide linked to sorbitan and a lipophilic group.28 
 
 Tween 20 - polyoxyethylene (20) sorbitan monolaureate 
 Tween 40 - polyoxyethylene (20) sorbitan monopalmitate  
 Tween 60 - polyoxyethylene (20) sorbitan monostearate  
 Tween 80 - polyoxyethylene (20) sorbitan monooleate 
 
Cremophor EL assimilation test: 
 Cremophor EL is polyoxyethylated ricinoleate, a non – ionic surfactant.  
Growth of certain strains of M. furfur and M. pachydermatis is promoted by 1 – 
10% cremophor EL.28, 77 
 
CHARACTERISATION OF MALASSEZIA SPECIES: 
 Based on the results of the above biochemical tests, the 14 species of 
Malassezia can be identified as follows according to the scheme suggested by 
Guillot et al and later modified by Mayser et al and Gueho et al.2, 3, 4, 5 
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Species 
 Catalase 
Esculin 
hydrolysis 
Tween
20 
Tween
40 
Tween
60 
Tween 
80 
Growth 
at 42˚C 
M. furfur + -/W+ + + + + + 
M.pachy 
dermatis +/V V +/V V V V + 
M. 
sympodialis + + +/- + + + + 
M. globosa + - + - - - - 
M. obtusa + + - - - - - 
M. restricta - - - - - - - 
M. dermatis + V + + + + + 
M. japonica + V - + + - + 
M. 
yamatoensis + V + - - - - 
M. sloofiae + - - - - W+ + 
M. nana + - + + V V V 
M. caprae + + V V V V - 
M. cuniculi + + - - - - + 
M. equina + - V V V - - 
 
V – Variable; W+   Weakly positive 
 All Malassezia species produce urease enzyme and hence are urease test 
positive. 
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ANIMAL PATHOGENICITY: 
 Experimental studies to infect common laboratory animals like guinea pigs 
and Swiss white mice have resulted in the development of experimental dermatitis 
showing hyperkeratosis at pilous bulbs and follicular ostia.8, 28 
 
IMMUNODIAGNOSIS: 
 Cell mediated immunity can be assessed by lymphocyte blastogenesis in 
response to specific fungal antigens.   Antibody titers specific to Malassezia 
species can be determined by solid phase ELISA.8 Indirect immunofluorescence 
staining of Malassezia yeasts in scales and cultures is possible by.11 
 
MOLECULAR DIAGNOSIS: 
 Molecular methods provide definitive identification of the fungus for 
diagnostic and epidemiological purposes.  They lead to a better understanding of 
the epidemiology and ecology of Malassezia species and aid in rapid screening of 
large number of isolates in epidemiological surveys.28 
 
 Estimation of the G+C content of chromosomal DNA and   25S rRNA 
sequencing were the methods initially employed.  Other methods include  
karyotyping, restriction fragment length polymorphism (RFLP), multilocus 
enzyme electrophoresis (MLEE), PCR fingerprinting, randomly amplified 
polymorphic DNA analysis (RAPD) and PFGE.8, 28 
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 Heterogeneity within the species has made RAPD unreliable for speciation.  
Karyotyping, though robust, is labour intensive and time consuming.  At present, 
PFGE is the only method that allows reliable differentiation of various strains of 
Malassezia species.8, 28 
 
ANTIFUNGAL SUSCEPTIBILITY TESTING: 
Determination of minimal inhibitory concentration (MIC) by broth  
microdilution method : 
 The Clinical Laboratory Standards Institute (CLSI) has recommended a 
broth microdilution method for testing the antifungal susceptibility of yeasts 
(Document M27-A3). However, this method is not applicable for the 
susceptibility testing of Malassezia species because they are lipophilic, except 
for M. pachydermatis. Hence standardized assays are not available for the 
determination of the in vitro susceptibilities of these yeasts to any of the 
antifungal agents.  
 
 As all Malassezia species are urease positive,19  a modification of the CLSI 
M27-A3 document method using Christensen's urea broth with the addition of 
0.5% Tween 40 and 0.1% Tween 80, has been suggested by some authors20, 86 for 
evaluation of the optimal antifungal susceptibility patterns of the isolates.  Various 
other media have been evaluated in different studies, notable among which are 
 
 RPMI 1640 with 1% glycerol, 1% peptone, 1.8% glucose, and 0.05% 
Tween 8086 
 Modified Leeming and Notman medium88 
(The above media measure growth inhibition) 
38 
 
 Modified Leeming and Notman broth with alamar blue, a calorimetric 
indicator88(measures metabolic activity) 
 Though numerous antifungal susceptibility profiles have been reported for 
yeasts in general, very few are available for the different Malassezia species. 
Earlier studies were mostly done on M. furfur.  The in vitro susceptibility of 
Malassezia species to various antifungal agents has been performed by Gupta and 
Colleagues8 and other authors.88, 91 – 94    Studies have shown that the susceptibility 
patterns to azole antifungals have been species dependent, with low MICs (<1 
μg/ml) for most Malassezia spp. and high endpoints (MIC90 values 1 to ≥8 μg/ml) 
for M. globosa and M. restricta.88, 91 – 94 
 
TREATMENT OF MALASSEZIA INFECTIONS: 
 The three major groups of drugs in clinical use for the treatment of 
superficial infections caused by Malassezia yeasts are azoles, polyenes and 
pyrimidines. The azole and polyene antifungal agents are directed against 
ergosterol, that plays a key role in maintaining the fluidity and integrity of the 
fungal plasma membrane and in the proper functioning of membrane bound 
enzymes. Inhibition of14 α-demethylase by azoles results in ergosterol depletion 
and accumulation of sterol precursors, leading to the formation of an ineffective 
plasma membrane with altered structure and function. 90 
 
 Topical creams, lotions and shampoos of 2% ketoconazole, 2% 
miconazole, 1% clotrimazole, whitfield’s ointment, 2.5% selenium sulphide, 10% 
sulphur, 1% terbinafine, naftifine, 1% zinc pyrithione, 50%propylene glycol, 25% 
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sodium hyposulfite, 6% benzoyl peroxide and 1% ciclopirox oleamine are 
effective in treating Malassezia infections.  In addition, mild topical steroid 
creams may be used in seborrheic dermatitis.9 
 
 Treatment has to be given for 2 – 4 weeks in case of mild PV and longer in 
extensive involvement.  For SD, medicated shampoos are used once or twice 
weekly for 4 weeks and thereafter once or twice monthly for maintenance.29 
 
 Fluconazole or itraconazole in a dose of 200 mg/ day or ketoconazole 400 
mg/ day may be used for 5-7 days for extensive disease.  A single dose of 
Fluconazole 400 mg may be used as an alternative for PV. Pulse therapy of 
fluconazole 150 mg once or twice weekly for 2 – 3 months is being practiced.9, 10 
 
 Ketoconazole is to be taken with breakfast, including an acidic juice, and 
the patient should be advised to avoid bathing for the next 12 hours, as the 
primary route of drug delivery to the skin is through sweat.11 
 
 A significant proportion of patients however, have experienced failure with 
azole treatment due to the development of drug resistance in Malassezia species.  
The drug resistance may be attributed to the variable genotypes of azole – 
metabolizing CYP51 enzyme in Malassezia yeasts.97 
 
 Twice daily intermittent  application of 50% propylene glycol for 2 weeks 
has been used for the prevention of relapse. 
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 New topical agents, calcineurin inhibitors like tacrolimus 0.03% for 
children and 0.1%for adults and pimecrolimus 1% are used for their 
immunomodulatory effects.8 
 
 Fungemia may be treated with amphotericin B or fluconazole, prompt 
removal of the intravascular catheter and discontinuance of parenteral lipid 
infusions.9 
 
 Griseofulvin and flucytosine are not effective in the treatment of 
Malassezia infections.8, 89 
 
PROGNOSIS: 
 Malassezia skin infections are benign and self-limited, but recurrences are 
common because they are caused by endogenous flora.9   60 – 80% of the 
infections relapse or recur on account of genetic factors, hormonal factors or 
immunosuppression.9 
 
 PV is known for its chronicity, though long intervening periods of no 
lesions may be seen. Pigment alterations in PV may take months to resolve, 
especially with the hypopigmented variety.11 
 
 SD in infants is self-limited with a good prognosis while it is relapsing and 
chronic in adults.  Generalised flares and erythroderma also occur.25 
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MATERIALS AND METHODS 
 
 This study was carried out in the Mycology section of the Institute of 
Microbiology, Madras Medical College, Chennai, for a period of one year, 
enrolling patients from the Dermatology outpatient department (OPD) in   Rajiv 
Gandhi Government General Hospital, Chennai. 
 
Study design and study period: 
 This study was a Cross-sectional study, done for a period of one year from 
October 2013 to September 2014. 
 
Study population:  
 The study population consisted of one hundred patients, of  both sexes and 
all age groups, attending  the Dermatology OPD of Rajiv Gandhi Government 
General Hospital, Chennai, who satisfied the following criteria: 
 
Inclusion criteria: 
1. Patients with superficial skin lesions clinically diagnosed as pityriasis 
versicolor or 
2. Patients with superficial skin lesions cinically diagnosed as seborrheic 
dermatitis 
3. Only those patients whose skin scrapings were positive for the 
characteristic ‘spaghetti and meat ball’ appearance on potassium hydroxide 
mount were included in the study. 
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Exclusion criteria: 
1. Patients on topical antifungals within the preceding 2 weeks of visit, 
2. Patients on systemic antifungals within the preceding 4 weeks of visit and 
3. Patients whose skin scrapings were negative on KOH mount  
were excluded from the study.             
 
 Ethical clearance [Annexure 1] was obtained for the study from the 
Institutional Ethics Committee, and  informed consent [Annexure 3] was obtained 
from all the patients who participated in the study.  Patients belonging to study 
population were interviewed with a structured questionnaire [Annexure 2]. 
 
COLLECTION OF DATA:               
 Patients who satisfied the inclusion criteria were interviewed using a 
preformed structured questionnaire for collection of demographic details like 
name, age, sex, address, clinical data like presenting complaints, personal history, 
past medical history, history suggestive of associated immunocompromised state 
and family history. 
 
SPECIMEN COLLECTION: 
 The patients were made to sit comfortably in a well - lit area and the 
lesional sites were inspected.  The sites were cleansed with 70% isopropyl 
alcohol, allowed to dry and scrapings were obtained from  
 
1. hypopigmented or hyperpigmented scaly lesions in case of pityriasis 
versicolor, and 
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2. erythematous, greasy-looking areas of skin covered with loose flakes in the 
case of seborrheic dermatitis 
 
 on an alcohol cleansed,  flame-sterilized glass slide (7.5 x 2.5 cm) using the 
blunt end of  a flame-sterilized  no.15 size scalpel.8 
 
DIRECT EXAMINATION: 
POTASSIUM HYDROXIDE (KOH) MOUNT: 
 The scrapings were placed on a clean microscopic glass slide and a drop of 
a prepared mixture of 10% KOH with an equal volume of Parker Quink’s 
permanent blue ink [Appendix II - 1]was added.28  A coverslip was placed on the 
preparation and left aside for 10 to 20 minutes for digestion of keratin and other 
debris that might otherwise preclude better visualization of fungal elements. 
Parker Quink’s ink was added, so that the fungal elements take up the ink and 
stain bright blue against a background of digested keratinocytes.1, 8, 28 
 
 Examination under low power and high power objectives of the 
microscope revealed the characterisitic ‘banana and grapes’ or ‘spaghetti and 
meatball’ appearance of the short hyphal forms and yeast cells of Malassezia.21 
 
CULTURE: 
 The skin scrapings that showed the characteristic ‘banana and grapes’ 
appearance suggestive of Malassezia on KOH mount were inoculated under strict 
aseptic precautions onto two Sabouraud Dextrose Agar (SDA) slants [Appendix II 
- 5] containing 0.05% chloramphenicol and 0.05% cycloheximide in 6 x ¾ inches 
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size test tubes, and an overlay of sterile olive oil was made using a sterile 
disposable syringe on one of the slants. The inoculated slants were incubated at 
32˚C for 7 – 10 days and examined daily for cream coloured colonies with flat or 
raised surface.  Tubes that showed no growth after two weeks of incubation were 
discarded and considered culture negative. 
 
GRAM STAINING: 
 Gram staining [Appendix II - 2] of the above colonies showed Gram 
positive spherical or oval yeast cells with unipolar narrow–based or broad–based 
budding.1, 8 
 
BIOCHEMICAL TESTS: 
The following biochemical tests were done to identify Malassezia species:  
1. Urease  test 
2. Catalase test 
3. Esculin hydrolysis test 
4. Growth at 42˚ C 
5. Tween assimilation test  
 
UREASE TEST: 
 AllMalassezia speices are capable of hydrolyzing urea and this test, though 
not useful in speciation, is useful to eliminate cultures other than Malassezia like 
Ascomycetes and Candida, which commonly occur in the skin.28 
 
45 
 
 A loopful of growth from a 5 to 7 day old culture was suspended in urea 
broth [Appendix II - 4] and incubated at 37˚C.  The results were read in 3 to 4 
hours and in case of doubtful reactions, the results were again read after 24 
hours.28, 86  All cultures that showed a colour change from yellow to bright pink in 
urea broth indicated the presence of urease enzyme and hence considered positive 
for urease test.  Any isolate that showed no colour change was considered 
negative for urease activity and those cultures were discarded as negative for 
Malassezia species. 
 
CATALASE TEST: 
 The enzyme catalase present in the members of the genus Malassezia 
breaks down hydrogen peroxide to produce nascent oxygen, which is evident by 
the production of effervescence. Using a sterile glass rod, a colony of Malassezia 
species was taken and immersed in a sterile test tube containing 3% hydrogen 
peroxide.2  Immediate effervescence suggested presence of catalase enzyme. Lack 
of catalase enzyme activity is characteristic of M. restricta.8, 28, 78 
 
ESCULIN HYDROLYSIS TEST: 
 Beta glucosidase enzyme activity of Malassezia yeasts was assayed using 
esculin agar [Appendix II – 6].  A loopful of colony was inoculated deep into the 
esculin agar and incubated at 37˚C for 24 hours.  A brownish black discoloration 
of the medium indicated the presence of beta glucosidase activity.M. sympodialis 
and M. obtusa are positive for beta glucosidase acitivity, while the other species 
are negative and hence show no discoloration of the esculin agar medium.8, 28, 48 
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GROWTH AT 42 ˚C: 
 Ability to grow at 42˚Cis a physiological characteristic used to differentiate 
Malassezia species. All cultures were inoculated onto another SDA slope and 
incubated at 42˚C for one week. M. pachydermatis, M. furfur, M. sympodialis, 
M.slooffiae, M. dermatis, M. japonica and M. cuniculi are the species that are 
capable of growth at 42˚C within 4 – 5 days.2, 8, 77 
 
TWEEN ASSIMILATION TEST: 
 This test was done according to the method proposed by Guillot et al.2 107 
CFU/ml of yeast suspension was made in 2 ml of distilled water and poured into a 
plate containing 16 ml SDA with 0.05% chloramphenicol and 0.05% 
cycloheximide at 45 - 50˚C.  After evenly spreading the inoculum, the plates were 
allowed to solidify and four wells each of 2 mm diameter were made and filled 
with 30 µl of the Tween compounds [Appendix II – 5], namely, 10% Tween 20, 
0.5% Tween 40, 0.5% Tween 60 and 0.1%Tween 80 and the plates were 
incubated for upto a week at 31˚C.  The plates were observed for the presence of 
growth around the individual wells on days 2, 4 and 7.8, 28, 2 
 
 As the Tween compounds are water–soluble, a concentration gradient was 
formed around each well and the utilization of the Tweens was assessed by the 
degree of precipitation of the lipophilic yeasts around individual wells.78 
 
 Based on the results obtained in the above tests, Malassezia species were 
identified according to the scheme suggested by Gueho et al2 as follows:  
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                                                         CULTURE ON 
                                                                                       
         Growth present                                                Growth present     
                                                                                                  M. pachydermatis     
           Negative                              Positive 
                  M.restricta                                            
                     
                                              
         Assimilates          Assimilates           Assimilates                 No specific  
       20,40,60,80            40,60,80                  20,40,60                       pattern 
 
         Weakly  
        positive                 Positive                 Negative                           
                M. furfur     M. sympodialis          M. slooffiae 
                    
                                                                      Positive                  Negative                                                    
                                                                         
                                                             M. obtusa            M. globosa 
                        
 
SDA without olive oil overlay        SDA with olive oil overlay
  Catalase test
  Tween assimilation patterns using Tweens 20, 40, 60, 80 
                           Beta glucosidase activity        
Beta glucosidase activity 
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ANTIFUNGAL SUSCEPTIBILITY TESTING: 
 The Malassezia species identified by the above physiological and 
biochemical tests were subjected to antifungal susceptibility testing by broth 
microdilution method. 
 
DETECTION OF MINIMAL INHIBITORY CONCENTRATION BY 
BROTH MICRODILUTION METHOD : 
 A modification of the CLSI recommended (Document M27-A3) broth 
microdilution method for testing the antifungal susceptibility of yeasts using 
Christensen's urea broth with the addition of Tween 40 (0.5%) and Tween 80 
(0.1%), as suggested by some authors was used for antifungal susceptibility 
testing of the isolates. 20, 86 
 
REFERENCE STRAIN: 
 Cryptococcus neoformans – ATCC® 90112 
 
ANTIFUNGAL AGENTS USED: 
 Fluconazole, Itraconazole, Voriconazole, Ketoconazole and Amphotericin 
B were the antifungal agents used for antifungal susceptibility testing of 
Malassezia species. 
 
 The antifungal agents were procured from Global Pharmaceuticals Private 
Limited, Chennai. 
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RANGE OF CONCENTERATIONS  TESTED: 
 For each drug, the following range of concentrations were prepared: 
 
Itraconazole  - 0.0313 to 16 µg/ml 
Fluconazole          -    0.125 to  64 µg/ml 
Ketoconazole        -   0.0313 to 16 µg/ml 
Voriconazole         -   0.0313  to 16 µg/ml   
Amphotericin B     -  0.0313  to 16 µg/ml   
 
WEIGHING OF ANTIFUNGAL DRUGS: 
 
Volume (ml) x Concentration (μg/ml) 
Weight (mg) =    ---------------------------------------------------------- 
Assay Potency (μg/mg) 
 
 
Weight (mg)  x Assay Potency (μg/mg) 
Volume (ml) =  ---------------------------------------------------------- 
Concentration (μg/ml) 
 
REAGENTS REQUIRED: 
 Antifungal agents  
 A 7 day old culture for inoculum preparation 
 0.85% Normal saline 
 Urease broth medium 
 TWEEN 40 
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 TWEEN 80 
 DMSO (Dimethyl Sulfoxide) 
 Sterile 96-well microtiter plate 
 Distilled water 
 
MEDIUM  
 Urease broth with phenol red as indicator (HiMedia) was prepared as per 
manufacturer’s instructions and supplemented with 0.5% Tween 40 and 0.1% 
Tween 80 to enable the medium to support the growth of lipophilic Malassezia 
species.86 
 
 DMSO was used for dissolving water insoluble drugs like itraconazole, 
ketoconazole, voriconazole and amphotericin B. 
 
 DISTILLED WATER was used for dissolving the water soluble drug 
fluconazole. 
 
PREPARATION OF STOCK SOLUTION OF DRUGS: 
 All drugs were purchased as powders and were stored in the dark at 4°C. 
Stock solutions of ketoconazole, itraconazole, voriconazole and amphotericin B 
were prepared in dimethyl sulfoxide at concentrations of 1,600 μg/ml.   
 
 Stock solution of fluconazole was prepared in distilled water at a 
concentration of 5,120 μg/ml.  
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 All the stock solutions were stored in the dark at −70°C for use within 3 
months in case of azoles and one month in the case of amphotericin B.94 
 
INOCULUM PREPARATION 
1. Four to Five similar-looking Malassezia colonies grown on SDA were 
taken and suspended in 0.04% Tween 80 in distilled water at pH 7.4. 
2. The suspension was then vortexed for 15 seconds. 
3. The resulting suspension was adjusted to an absorbance of  0.5 Mc Farland 
Standard at 530 nm wavelength using a spectrophotometer, which will 
correspond to a yeast suspension of 1 × 106 to 5 × 106cells/ml. 
4. The resulting suspension was further diluted 1:50 and then a further 1:20 
with the standard medium so that the test inoculum is 1 × 103  to 5 × 103 
CFU/ml. 
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PREPARATION OF SERIES OF DILUTIONS OF WATER INSOLUBLE 
DRUGS 
 The water insoluble drugs Amphotericin B, Itraconazole, Ketoconazole and 
Voriconazole were dissolved in DMSO.  Initial drug concentration of 1600 μg/ml 
(STOCK) was kept in Tube 1.  Intermediate drug concenterations were prepared 
as in the following table: 
 
Tubes in Row 
I 1 2 3 4 5 6 7 8 9 10 
Amount of 
DMSO 
- 
0.5 
ml 
1.5 
ml 
3.5 
ml 
0.5 
ml 
1.5 
ml 
3.5 
ml 
0.5 
ml 
1.5 
ml 
3.5 
ml 
Amount of 
drug added 
(ml) 
- 
0.5 
From 
tube 
1 
0.5 
From 
tube 
1 
0.5 
from 
tube 
1 
0.5 
From 
tube 
4 
0.5 
From 
tube 
4 
0.5 
From 
tube 
4 
0.5 
From 
tube 
7 
0.5 
From 
tube 
7 
0.5 
From 
tube 
7 
Intermediate   
drug 
concenteration 
(μg/ml)   in 
Row I 
1600 800 400 200 100 50 25 12.5 6.25 3.13 
 
 Then the final drug concentrations were prepared by diluting the prepared 
intermediate drug concentrations in urea broth as follows: 
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PREPARATION OF FINAL CONCENTRATION  OF WATER 
INSOLUBLE      ANTIFUNGAL AGENTS  
Tubes in row 
II 1 2 3 4 5 6 7 8 9 10 
Amount of 
urea broth  
(ml) 
 
4.9 
 
4.9 
 
4.9 
 
4.9 
 
4.9 
 
4.9 
 
4.9 
 
4.9 
 
4.9 
 
4.9 
Amount of 
drug added 
from 
corresponding 
row I tubes (1-
10) (ml) 
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
Final   drug 
concenteration 
in row II tubes 
(μg/ml) 
32 16 8 4 2 1 0.5 0.25 0.125 0.0625 
  
 Then, the finally diluted variable concentration of drugs were added to the 
diluted inoculum. 
 
ADDITION OF INOCULUM TO MICROTITER PLATE 
Microtiter 
plate wells 1 2 3 4 5 6 7 8 9 10 
Amount of 
drug added  
from row II 
tubes (ml) 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
Amount of 
inoculum 
added  (ml) 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
Final drug 
concentration 
in each well 
(μg/ml) 
 
16 
 
8 
 
4 
 
2 
 
1 
 
0.5 
 
0.25
 
0.125 
 
0.0625 
 
0.0313
54 
 
 
CONTROLS:  
 Growth  control containing 0.1 ml urea broth and 0.1 ml of the inoculum, 
and  drug  control containing 0.1 ml of the stock solution of the corresponding 
drug were included. 
 
INCUBATION: 
 The seeded microtiter  plates were incubated at 32°C for 72 hours. 
 
PREPARATION OF STOCK SOLUTION AND SERIES OF DILUTIONS 
OF WATER  SOLUBLE DRUGS   
 Stock solution in a concentration of 5120 μg/ml was prepared by dissolving 
the water soluble drug Fluconazole in distilled water (initial concentration of the 
drug in tube 1). Then, a series of intermediate drug concentrations were prepared 
with urea broth as follows: 
 
Tubes in row 
I 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
Amount of 
urea broth 
(ml) 
 
7 
 
1 
 
3 
 
1 
 
1.5 
 
3.5 
 
1 
 
1.5 
 
3.5 
 
1 
Amount of 
drug (ml) 
 
From 
tube 
1 
From 
tube 
1 
From 
tube  
1 
From 
tube  
3 
From 
tube 
 3 
From 
tube  
3 
From 
tube  
6 
From 
tube  
6 
From 
tube  
6 
From 
tube  
9 
1 1 1 1 0.5 0.5 1 0.5 0.5 1 
Intermediate 
drug 
concentration 
(μg/ml)   in 
row I 
 
 
640 
 
 
320 
 
 
160 
 
 
80 
 
 
40 
 
 
20 
 
 
10 
 
 
5 
 
 
2.5 
 
 
1.25
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     Then the final concentration of drug was prepared from the intermediate 
drug concentration by diluting in urea broth medium. 
 
 PREPARATION   OF  FINAL  CONCENTERATION  OF  WATER 
SOLUBLE ANTIFUNGAL DRUGS: 
Tubes in row II 1 2 3 4 5 6 7 8 9 10 
Amount of urea broth 
(ml) 
 
4 
 
4 
 
4 
 
4 
 
4 
 
4 
 
4 
 
4 
 
4 
 
4 
Drug added from 
corresponding row I 
tubes (1-10) (ml) 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
Final   drug 
concentration(μg/ml)   
in row II tubes 
 
128
 
64 
 
32 
 
16 
 
8 
 
4 
 
2 
 
1 
 
0.5 
 
0.25
  
 Then the finally diluted  variable concentration of drugs  were added to the 
diluted inoculum. 
 
ADDITION OF INOCULUM TO MICROTITER PLATE: 
Microtiter plate 
wells 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
Amount of drug 
added to 
microtiter plate 
from row II 
tubes (ml) 
 
 
0.1 
 
 
0.1 
 
 
0.1 
 
 
0.1 
 
 
0.1 
 
 
0.1 
 
 
0.1 
 
 
0.1 
 
 
0.1 
 
 
0.1 
Amount of 
inoculum added 
(ml) 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
0.1 
 
Final drug 
concentration in 
each well 
(μg/ml) 
 
64 
 
32 
 
16 
 
8 
 
4 
 
2 
 
1 
 
0.5 
 
0.25 
 
0.125
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CONTROLS:  
 Growth  control containing 0.1 ml urea broth and 0.1 ml of the inoculum, 
and  drug  control containing 0.1 ml of the stock solution of the corresponding 
drug were included. 
 
INCUBATION: 
 The seeded microtiter plates were incubated at 32°C for 72 hours. 
 
READNG OF RESULTS FOR MIC BY BROTH MICRODILUTION 
METHOD: 
 Minimal Inhibitory Concentration was determined by comparing the 
amount of growth in the growth control well with the amount of growth in the 
wells containing the antifungal agent and a numerical score was given as follows: 
Numerical Score : 
 
0  -    Optically clear or absence of growth 
1  -    Approximately 25% of the growth control or slight growth 
2  -    Approximately  50% of the growth control or prominent reduction  
  in growth 
4  - Approximately as of the growth medium or slight reduction in the  
  growth (75%  of  growth control) 
5 -   No reduction in the growth 
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INTERPRETATION:  
 80% growth inhibition corresponding to a numerical score of 3 was taken 
as the end point for azoles.  Complete absence of growth, corresponding to a 
numerical score of 0 was taken as the end point for amphotericin B.86, 88 
 
 MIC50 and MIC90 were determined for the isolates.  MIC of ATCC® 
control strain was confirmed to be within the expected range, for the validity of 
the interpretation for the test strains.   
 
 To date, no standardized breakpoints are available for the MIC of various 
antifungal agents in the case of Malassezia species. 
 
STATISTICAL ANALYSIS: 
 Statistical analysis was done using Statistical Package for Social Sciences 
16 (SPSS 16) and Epi-info softwares.  The results were analyzed by Pearson’s Chi 
square test.  P value less than 0.05 is considered to correlate with statistical 
significance.                                                                  
 
 
 
 
 
 
 
RESULTS 
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RESULTS 
 
 This study was done for a period of one year from October 2013 to 
September 2014, at the Institute of Microbiology, Madras Medical College and 
the Department of Dermatology, Madras Medical College and Rajiv Gandhi 
Government General Hospital, Chennai.   
 
 A total of 100 patients who were clinically diagnosed to have either 
pityriasis versicolor (PV) or seborrheic dermatitis (SD), and whose skin scrapings 
showed the  characteristic  ‘spaghetti and meat ball appearance’  on 10% 
potassium hydroxide  – Paker Quink’s blue ink mount were chosen for the study,  
from those who  attended the Dermatology outpatient department (OPD). The 
study population consisted of patients belonging to all age groups and both sexes.  
 
Table 1:  Distribution of pityriasis versicolor and  
seborrheic dermatitis cases in the study population (n = 100) 
 
Infection No. of cases Percentage  (%) 
Pityriasis versicolor 73 73 
Seborrheic dermatitis 27 27 
TOTAL 100 100 
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 Of the 100 cases chosen for the study, 73 were clinically diagnosed to have 
pityriasis  versicolor (PV) and 27 were clinically diagnosed to have seborrheic 
dermatitis (SD). 
 
PITYRIASIS VERSICOLOR (PV): 
 
Table 2: Age and gender distribution of  
Pityriasis versicolor cases in the study population (n=73) 
 
Age 
in years 
Total  no. of  cases Male patients Female patients 
Number % Number % Number % 
10 - 19 13 17.8 9 12.3 4 5.5 
20 - 29 31 42.5 24 32.9 7 9.6 
30 - 39 16 21.9 9 12.3 7 9.6 
40 – 49 11 15.1 9 12.3 2 2.7 
50 – 59 0 0 0 0 0 0 
60 - 69 2 2.7 2 2.7 0 0 
TOTAL 73 100 53 72.6 20 27.4 
 
 Majority of the patients with pityriasis versicolor belonged to the 20 – 29 
years age group in both sexes, with an overall male predominance (53 males out 
of the total 73 PV cases) (72.6%).  The median age of occurrence of PV was 
found to be 24 years.  
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Figure 1: Gender distribution of Pityriasis versicolor cases in the study 
population (n = 73) 
 
 
Figure 2: Age and gender distribution of Pityriasis versicolor cases 
 (n = 73) 
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Table 3: Distribution of PV lesions in various body sites in  
the study group (n = 73) 
Major body site involved No. of cases of PV Percentage (%) 
Back 37 50.7 
Chest 11 15 
Face and neck 18 24.7 
Arms 7 9.6 
TOTAL 73 100 
 
 Majority of the patients with pityriasis versicolor presented with lesions on 
the back (50.7%), followed by face and neck (24.7%).  Of the total 73 cases, there 
were 35 patients with multiple site involvement, in whom the predominant site 
involved was taken into account. 
 
Figure 3: Distribution of PV lesions in various body sites (n = 73) 
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Table 4: Type of Pigmentation of PV lesions in the study population (n=73) 
Type of Pigmentation No. of cases Percentage 
Hypopigmented PV 46 63.1 % 
Hyperpigmented PV 27 36.9 % 
TOTAL 73 100 % 
 
 The hypopigmented type of pityriasis versicolor was more common 
(63.1%) than the hyperpigmented type.. 
 
Table 5: Frequency of pruritus in patients with pityriasis versicolor in the 
study population (n = 73) 
Pruritus No. of cases with PV Percentage 
Present 21 28.8 % 
Absent 52 71.2 % 
TOTAL 73 100 % 
  
 Pruritus was present only in 28.8%of pityriasis versicolor cases. 
 
Table 6: Family history of pityriasis versicolor in the study group (n = 73) 
Family history of  PV No. of PV cases Percentage 
Present 20 27.4 % 
Absent 53 72.6 % 
TOTAL 73 100 % 
 
 History of similar hypopigmented or hyperpigmented scaly lesions in other 
family members was present in 27.4% of pityriasis versicolor cases. 
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Table 7: Frequency of occurrence of pityriasis  versicolor lesions in the study 
population (n = 73) 
Presentation of PV No. of PV cases Percentage 
First episode 49 67.1 % 
Recurrent lesions 24 32.9 % 
TOTAL 73 100 % 
 
 Recurrent lesions were found in 24 cases (32.9%) and the remaining 49 
cases (67.1%) presented for the first time with lesions suggestive of PV. 
 
Figure 4: Distribution of patients with pruritus, family history and history of 
recurrence of PV in the study population (n = 73) 
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Table 8: Degree of scaling in PV lesions in the study population ( n = 73) 
Degree of 
Scaling 
No. of cases with PV 
Total (%) Hypopigmented (%) Hyperpigmented (%) 
Mild 21 (28.8%) 14 (19.2 %) 7 (9.6 %) 
Moderate 40 (54.8%) 31 (42.5 %) 9 (12.3 %) 
Severe 12 (16.4%) 1 (1.3 %) 11 (15.1 %) 
TOTAL 73 (100%) 46 (63 %) 27 (37 %) 
 
 Majority (54.8%) of the patients with pityriasis versicolor presented with 
moderate amount of scaling in the lesions.  28.8% had mild scales and 16.4% had 
severe degree of scaling in the lesions.   Severe scaling was very common in the 
hyperpigmented type of PV (15.1%) compared to hypopigmented PV (1.3%). 
 
Figure 5: Degree of scaling in PV lesions in the study population(n = 73) 
 
65 
 
 
Table 9: Isolation rate of Malassezia spp. from pityriasis versicolor cases in 
the study population (n = 73) 
Culture for Malassezia spp. No. of PV cases Percentage 
Culture positive 56 76.7 % 
Culture negative 17 23.3 % 
TOTAL 73 100 % 
 
 The isolation rate of Malassezia species from PV cases was 76.7%, that is, 
out of the 73 samples of skin scrapings collected from clinically diagnosed PV 
cases who showed the characteristic ‘spaghetti and meatball’ appearance on KOH 
mount, 56 (76.7 %) yielded growth on Sabouraud dextrose agar with olive oil 
overlay and the remaining 17 (23.3%) were culture negative.  
 
Figure 6: Isolation rate of Malassezia spp. from pityriasis versicolor  
cases in the study population (n = 73) 
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Table 10: Comparison of culture positivity in the hypopigmented and 
hyperpigmented types of PV in the study population (n = 73) 
Type of PV Total 
Culture result in PV 
Positive Negative % of culture positivity 
Hypopigmented PV 46 31 15 67.4 % 
Hyperpigmented PV 27 25 2 92.6 % 
 
 Isolation rate of Malassezia species from PV was more with the 
hyperpigmented type, (25 cases out of 27; 92.6%), compared to the 
hypopigmented type (31 out of total 46; 67.4%).  This result is statistically 
significant ( p value 0.013). 
 
Figure 7: Comparison of culture positivity in the hypopigmented and 
hyperpigmented types of PV in the study population (n = 73) 
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Table 11: Correlation between the duration of lesions and isolation rate of 
Malassezia species from PV in the study population  (n =73) 
Duration of PV 
lesions 
No. of  
PVcases 
(%) 
Culture positive  PV cases 
Number Percentage of culture positivity in each group 
1 week to 1 month 16 (21.9%) 12 75 % 
>1 month to 6 months 44 (60.3%) 38 86.4 % 
>6 months to 1year 12 (16.4%) 6 50 % 
>1 year 1 (1.4%) nil nil 
 
 Majority (60.3%) of the PV cases had skin lesions for a duration of  1 to 6 
months.  Culture positivity was high in those patients (86.4%). This result is 
statistically significant (P value 0.015). 
 
Figure 8: Correlation between the duration of PV lesions and culture 
positivity (n = 73) 
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Table 12: Distribution of Malassezia species among the culture positive PV 
cases in the study population (n = 56) 
Malassezia species No. of isolates in PV Percentage 
M. globosa 30 53.6 % 
M. sympodialis 12 21.4 % 
M. furfur 7 12.5 % 
M. restricta 5 8.9 % 
M. obtusa 2 3.6 % 
TOTAL 56 100 % 
 
 M. globosa was the most common species isolated (53.6%) from PV cases, 
followed by M. sympodialis, M. furfur, M. restricta and M. obtusa.   
Figure 9: Distribution of Malassezia species among the culture positive PV 
cases ( n = 56) 
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Table 13: Correlation between the site of PV lesion and Malassezia spp. 
isolated in the culture positive study population(n = 56) 
Malassezia 
species 
(n = 56) 
Site of PV lesion and the number of Malassezia isolates 
BACK(n =32) FACE (n = 12) CHEST (n =9) ARM (n = 3) 
No. % No. % No. % No. % 
M. globosa 19 59.4 % 7 58.4 % 3 33.3 % 1 33.3 % 
M. sympodialis 5 15.6 % 3 25 % 4 44.5 % 0 0 % 
M. furfur 6 18.8 % 1 8.3 % 0 0 % 0 0 % 
M. restricta 2 6.2 % 1 8.3  % 1 11.1 % 1 33.3 % 
M. obtusa 0 0% 0 0 % 1 11.1 % 1 33.3 % 
TOTAL 32 100 % 12 100 % 9 100 % 3 100 % 
 
 M. globosa was the most common species isolated form back (19 cases) 
(59.4%) and face (58.4%) lesions.  M. sympodialis was the predominant species 
isolated from chest (4 cases) (44.5%).This result is not statistically significant  (p 
value = 0.066). 
Figure 10: Correlation between the site of PV lesion and the  
Malassezia spp. isolated(n = 56) 
Back Chest Face Arm
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Table 14: Correlation between type of PV and isolation rate of various 
Malassezia spp. in culture positive PV cases (n = 56) 
 
Malassezia spp. 
 
Total no. 
of isolates 
Type of Culture positive PV lesions 
Hyperpigmented 
(n = 25) 
Hypopigmented 
(n = 31) 
No. of isolates % No. of isolates % 
M. globosa 30 9 36% 21 67.7%
M. sympodialis 12 7 28% 5 16.1%
M. furfur 7 5 20% 2 6.5% 
M. restricta 5 2 8% 3 9.7% 
M. obtusa 2 2 8% 0 0% 
TOTAL 56 25 100% 31 100% 
 
 M. globosa was the most common isolate in both the hypopigmented and 
hyperpigmented types of PV. 
 
Figure 11: Distribution of various Malassezia species in the PV types (n=56) 
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Table 15: Correlation between the PV episode and Malassezia spp. isolated 
from culture positive PV cases in the study population (n = 56) 
Malassezia spp. No. of isolates 
Culture positive PV lesions 
First episode (%) Recurrent lesions (%) 
M. globosa 30 22 (39.3%) 8 (14.2%) 
M. sympodialis 12 8 (14.3%) 4 (7.1%) 
M. furfur 7 5 (8.9%) 2 (3.6%) 
M. restricta 5 3 (5.4%) 2(3.6%) 
M. obtusa 2 Nil (0 %) 2 (3.6%) 
TOTAL 56 38 (67.9%) 18 (32.1%) 
 
 M. globosa was the most common species isolated from both fresh cases 
(39.3%) and recurrent cases (14.2%) of PV, followed by M. sympodialis in both 
groups. 
  
Figure 12: Correlation between the episode of PV lesion and Malassezia 
species isolated (n = 56) 
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Table 16: Frequency of various risk factors associated with pityriasis 
versicolor in the study population ( n = 73) 
 
Risk factor No. of PV cases Percentage 
Diabetes mellitus 4 5.5 % 
Immunocompromised 
status   9 12.3 % 
Intake of steroids or other 
immunosuppressive drugs 5 6.9 % 
Use of bath oils 23 31.5 % 
Excessive sweating 28 38.4 % 
 
 (   Rheumatoid arthritis, tuberculosis, post renal transplant state, HIV 
infection were the immunocompromised states encountered in PV patients in  the 
study population) 
 
 Risk factors like excessive sweating, use of bath oils and 
immunocompromised status were present in 28 cases (38.4%), 23 cases (31.5%) 
and 9 cases (12.3%)  of  PV respectively.  But excessive sweating  as a risk factor 
for PV was found to be  statistically insignificant in this study  ( p value 0.39). 
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SEBORRHEIC DERMATITIS: 
 In this study done for a period of one year from October 2013 to September 
2014,27 clinically diagnosed  seborrheic dermatitis cases with the characteristic 
‘spaghetti and meat ball appearance’ on direct KOH mount of skin scrapings from 
seborrheic dermatitis lesions were included.   
Table 17: Age and gender distribution of seborrheic dermatitis in the study 
population  ( n = 27) 
Age in 
Years 
Total patients Male Patients Female Patients 
No. % No. % No. % 
20 - 29 5 18.5 % 4 14.8 % 1 3.7 % 
30 - 39 9 33.3 % 7 25.9 % 2 7.4 % 
40 - 49 12 44.5 % 8 29.6 % 4 14.9 % 
50 - 59 1 3.7 % 1 3.7 % 0 0 % 
TOTAL 27 100 % 20 74 % 7 26 % 
 
 In all age groups, males (20 cases; 74%) were found to be affected more 
commonly than females (7 cases; 25.9%). 
 
 Majority of those affected with SD belonged to the 40 – 49 years age group 
in both sexes (12 cases; 44.44%), followed by the  30 – 39 years age group (9 
cases; 33.33%). 
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Figure 13: Gender distribution of seborrheic dermatitis in the study 
population (n = 27) 
 
Figure 14: Age and Sex distribution of patients with seborrheic dermatitis in 
the study population (n = 27) 
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Table 18: Distribution of SD lesions in various body sites in the study 
population (n = 27) 
 
Major body site involved No. of SD cases Percentage 
Face 9 33.33 % 
Scalp 8 29.63 % 
Chest & back 5 18.52 % 
Neck 4 14.81 % 
Arm 1 3.71 % 
TOTAL 27 100 % 
 
 Among the body sites involved in SD, face was the most common site  (9 
cases; 33.33%) , followed by the scalp (8 cases; 29.63%) . 
Figure 18: Distribution of SD lesions in various body sites in the study 
population (n = 27) 
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Table 19: Frequency of occurrence of SD in the study population (n=27) 
Presentation of SD No. of SD cases Percentage 
First episode 18 67 % 
Recurrent lesions 9 33 % 
TOTAL 27 100 % 
 
 33% of the patients with SD had recurrent lesions.  SD involving scalp was 
found to recur commonly, compared to lesions at the other sites.   
Table 20: Frequency of culture positivity for Malassezia species in SD cases in 
the study population (n = 27) 
Culture for Malassezia spp. No. of SD cases Percentage 
Positive 14 52 % 
Negative 13 48 % 
TOTAL 27 100 % 
 
          The isolation rate of Malassezia species from SD lesions was 52%.   
 
Figure 16: Frequency of culture positivity in SD cases  (n = 27) 
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Table 21: Correlation between the site of SD lesion and culture positivity for 
Malassezia spp. in the study population ( n = 27) 
 
Site of SD 
lesion  
No. of SD cases 
Total  
(n=27) 
Culture positive (n=14) Culture negative(n=13) 
No. %  No. % 
Face 9 4 44.4 % 5 55.6 % 
Scalp 8 6 75 % 2 25 % 
Chest & back 5 3 60 % 2 40 % 
Neck 4 1 25 % 3 75 % 
Arm 1 0 0 % 1 100 % 
 
 Culture positivity for Malassezia spp. was high with scalp lesions(75%),  
followed by chest and back lesions (60%).  But this correlation was statistically 
insignificant (p value = 0.36). 
 
Figure 17: Correlation between site of lesion and culture positivity in SD (n = 27) 
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Table 22: Distribution of Malassezia isolates in culture positive seborrheic 
dermatitis cases in the study population (n = 14) 
 
Malassezia species No. of culture positive SD cases Percentage 
M. globosa 7 50 % 
M. furfur 4 28.6 % 
M. sympodialis 2 14.3 % 
M. restricta 1 7.1 % 
TOTAL 14 100 % 
 
 M. globosa was the most frequently isolated species (50%) in SD, followed 
by M. furfur (28.6%), M. sympodialis (14.3%) and M. restricta (7.1%). 
 
Figure 18: Distribution of Malassezia species in culture positive seborrheic 
dermatitis cases in the study population (n = 14) 
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Table 23: Correlation between site of lesion and the Malassezia  species 
isolated from culture positive SD cases (n = 14) 
 
Malassezia 
species 
Site of SD lesion and no. of Malassezia isolates 
Face (n= 4) Scalp (n = 6) Chest & back (n = 3) Neck (n = 1)
No. % No. % No. % No. % 
M. globosa 2 50% 3 50% 2 66.7% 0 0% 
M. furfur 1 25% 2 33% 1 33.3% 0 0% 
M. sympodialis 0 0% 1 17% 0 0% 1 100%
M. restricta 1 25% 0 0% 0 0% 0 0% 
 
 M. globosa was the most common species isolated from SD lesions on 
chest & back (66.7%), face (50%) and scalp (50%).  M. furfur was the second 
common species form these three sites. 
Figure 19: Correlation between site of lesion and the Malassezia spp. isolated 
from culture positive SD cases (n = 14) 
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Table 24: Correlation between duration of lesions and isolation rate of 
Malassezia species from SD lesions in the study population (n = 27) 
 
Duration of lesions 
in SD 
Total cases (n=27) Culture positive cases (n=14) 
No. % No. % 
<3months 9 33.33% 3 33 % 
3 months to 1 year 12 44.44% 8 66 % 
>1 year 6 22.22% 3 50 % 
 
 The duration of lesions in majority (44.44%) of the SD cases was 3 months 
to 1 year, and 66% (8 cases out of 12) of those in this duration were culture 
positive for Malassezia species. But this correlation was statistically insignificant   
(p value 0.39).    
 
Figure 20: Correlation between the duration of lesions and isolation rate of 
Malassezia species from SD lesions(n = 27) 
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Table 25: Association of SD lesions with immunocompromised status 
(n = 27) 
 
Immunocompromised status No. of  SD cases Percentage 
Diabetes 3 11 % 
Steroid intake 1 3.7 % 
HIV 2 7.4 % 
Total 6 22.1 % 
 
 Immunocompromised status was present in 6 out of the total 27  cases of 
seborrheic dermatitis.  11% of the SD patients were diabetics (3 cases) and 7.4% 
of them were HIV positive (2 cases). The remaining 21 cases of  SD did not have 
any associated immunocompromised status.   
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Table 26: Overall isolation rate of  Malassezia species  in PV and SD cases in 
the study population  (n = 100) 
Culture for 
Malassezia spp. Total cases
PV cases SD cases 
No. % No. % 
Positive 70 56 76.7% 14 52% 
Negative 30 17 23.3% 13 48% 
TOTAL 100 73 100% 27 100% 
 
 In this study, the isolation rate of Malassezia species from PV and SD 
lesions put together was 70%, the yield being higher in pityriasis versicolor 
lesions (56 out of 73; 76.7%), than seborrheic dermatitis lesions (14 out of 27;  
52%). 
 
Table 27: Overall isolation rate of various Malassezia species in culture 
positive PV and SD cases in the study population (n = 70) 
 
Malassezia species 
isolated 
No. of isolates in culture positive cases 
PV SD Total Percentage 
M. globosa 30 7 37 52.8 % 
M. furfur 7 4 11 15.7 % 
M. sympodialis 12 2 14 20 % 
M. restricta 5 1 6 8.6 % 
M. obtusa 2 0 2 2.9 % 
TOTAL 56 14 70 100 % 
  
 M. globosa was the most commonly isolated species from both PV and SD 
lesions, whereas the second common species was M.sympodialis in PV and M. 
furfur in SD. 
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Figure 21: Overall isolation rate of  Malassezia species  in PV and SD in the 
study population    (n = 100)  (Table 26) 
 
 
Figure 22: Overall distribution of Malassezia species  in culture positive PV 
and SD cases (n = 70) (Table 27) 
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Table 28: The MIC ranges of antifungal agents tested against Malassezia 
species isolated from PV and SD lesions (n = 70) 
 
FLU – fluconazole,   KETO – ketoconazole,  ITRA – itraconazole,   
VORI – voriconazole, Amp B – amphotericin B.  
 
 A modification of the CLSI Document M27-A3  broth microdilution 
method for testing the antifungal susceptibility of yeasts was followed for the 
determination of MICs of the above antifungal agents for  all the Malassezia 
species isolated. In this study, the MIC range of Malassezia species were within 
the following range: Fluconazole  : 0.06 – 8μg/ml; Ketoconazole: 0.03 – 4μg/ml; 
Itraconazole  : 0.03 – 4μg/ml; Voriconazole : 0.03 – 8μg/ml; Amphotericin B : 
0.03 – 4μg/ml.  
 
 
 
 
 
 
Malassezia 
species 
FLU 
(μg/ml) 
KETO 
(μg/ml) 
ITRA 
(μg/ml) 
VORI 
(μg/ml) 
Amp B 
(μg/ml) 
M. globosa 
(n = 37) 0.06 – 8 0.06 – 4 0.03 - 4 0.03 - 8 0.03 - 2 
M. sympodialis 
(n = 14) 0.06 – 4 0.06 – 0.25 0.03 - 1 0.03 – 0.5 0.06 - 1 
M. furfur 
(n = 11) 0.06 – 1 0.03 - 2 0.03 – 0.125 0.03 - 1 0.03 - 4 
M. restricta 
(n = 6) 0.06 – 1 0.06 - 2 0.03 – 4 0.06 - 4 0.03 - 4 
M. obtusa 
(n = 2) 0.25 - 2 0. 5 0.125 – 1 0.06 – 2 0.06 – 0.5 
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Table 29: MIC50 and MIC90 of the antifungal agents tested against Malassezia 
isolates from PV and SD lesions (n = 70) 
 
 MIC50 - The minimal inhibitory concentration at which 50% of the isolates are 
susceptible to the antifungal agent tested. 
 MIC90 - The minimal inhibitory concentration at which 90% of the isolates are 
susceptible to the antifungal agent tested. 
 
 MIC50 of the above antifungal agents for most of the Malassezia species 
were less than 1μg/ml, though a few strains of M. globosa and M. restricta had 
MIC  values as high as  8 μg/mlfor fluconazole and voriconazole in the case of 
some M. globosa strains and 4μg/ml for itraconazole, voriconazole and 
amphotericin B in the case of some M. restricta strains. 
 
 MIC50 and MIC90 values of amphotericin B were consistently low, 
indicating good sensitivity of  all species to this drug. 
Malassezia 
species 
(n = 70) 
Fluconazole 
(64-0.06 μg/ml) 
Ketoconazole 
(16-0.0313 
μg/ml) 
Itraconazole 
(16-0.0313 
μg/ml) 
Voriconazole 
(16-0.0313 
μg/ml) 
Amphotericin 
B (16 – 0.0313 
μg/ml) 
MIC50 μg/ml 
MIC90 μg/ml 
MIC50 μg/ml 
MIC90 μg/ml
MIC50 μg/ml 
MIC90 μg/ml
MIC50 μg/ml 
MIC90 μg/ml 
MIC50 μg/ml 
MIC90 μg/ml
M. 
globosa 
(n = 37) 
 
2 
 
8 
 
4 
 
4 
 
2 
 
4 
 
2 
 
8 
 
0.06 
 
2 
M. 
sympodialis 
(n = 14) 
 
0.5 
 
4 
 
0.125
 
0.25 
 
0.06 
 
1 
 
0.125
 
0.5 
 
0.06 
 
1 
M. furfur 
(n = 11) 
 
0.25 
 
1 
 
0.125
 
2 
 
0.125
 
0.125
 
0.5 
 
1 
 
0.25 
 
4 
M. 
restricta 
(n = 6) 
 
0.06 
 
1 
 
0.125
 
2 
 
0.06 
 
4 
 
4 
 
4 
 
0.125 
 
8 
M. obtusa 
(n = 2) 
 
0.25 
 
2 
 
0.25 
 
0.5 
 
0.125
 
1 
 
0.06 
 
2 
 
0.06 
 
0.5 
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DISCUSSION 
 
 In this cross sectional study conducted for a period of one year from 
October 2013 to September 2014 in the Institute of Microbiology, Madras 
Medical College in association with the Department of Dermatology, Rajiv 
Gandhi Government General Hospital(RGGGH), Chennai, the epidemiological 
profiles of the two most common skin infections caused by Malassezia species 
namely, pityriasis versicolor and seborrheic dermatitis were analysed in 100 
patients of whom 73 were clinically diagnosed to have pityriasis versicolor and 27 
were clinically diagnosed to have seborrheic dermatitis [Table 1]. 
 
PITYRIASIS VERSICOLOR: 
 PV is a chronic, recurrent, superficial pigmentary dermatosis caused by 
Malassezia yeasts, affecting in general all ages ,except children and the elderly, 
and medical attention is sought only for cosmetic concerns.   
 
 In this study, the age group most commonly affected with PV was 20 - 29 
years (42%) followed by 30 – 39 years (22%) [Table 2].  This is in accordance 
with the study by Sanjeev Grover et al 96  in 2003, where 39.6% of those affected 
with PV belonged to 21 – 30 years age group and 30% belonged to 31 – 40 years 
age group. Siddartha Dutta et al67 in 2002 and Gatha Rao et al61 in the same year, 
also reported a 39.6%  and 30% incidence repectively of PV in the 21 – 30 years 
age group.   Studies by Terragni et al51in 1991,  Michalowski et al52 in 1965  and 
Cullen et al 53 in 1963  have also shown pityriasis versicolor to be common in 
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adolescents and young adults.  This may be due to increased sebum production in 
the skin in these ages.   
 
 In the present study, males (72.6%) were more commonly affected with 
pityriasis versicolor than females (27.4%) [Table 2].  This is concordant with the 
study by Gatha Rao et al61 in 2002, who observed 73.3% incidence in male 
patients.  Gurumohan Singh et al54 in 1996 and Deepak Kumar et al62 in 2005 
reported 75.3% and 55.4% incidence in males. Imwidthya et al60 in 1988 have 
observed a higher incidence in females, which may be due to their increased 
beauty consciousness.  The higher incidence in males in this study, may be 
attributed to increased outdoor activities of males for occupational purposes, 
putting them at a higher risk of sun exposure and humidity, which favours  the 
growth of Malassezia yeasts. It might also be due to the proportionately higher 
male population attending RGGGH. 
 
 In this study, the major site of involvement of pityriasis versicolor was 
back (51%), followed by face and neck (29%) [Table 3].  This is similar to the 
study by Kristany et al83 in 2008 where 76.5 % lesions were in the back of the 
trunk, followed by 16% in chest.  Gatha Rao et al,61 reported 70% lesions in the 
back of trunk. Gupta et al in 2001 and Imwidthaya et al60 in 1988 also observed 
PV lesions to be common on the back, followed by face.  The higher involvement 
of the trunk, face and neck may be due to the presence  numerous sebaceous 
glands in these sites and also due to the hot and humid climate prevalent in South 
India, resulting in excessive sweating in these sites.   
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In the present study, hypopigmented lesions (63.1%) were more common 
compared to the hyperpigmented lesions (36.9%)[Table 4].  This correlates with 
the studies conducted by Imwidthya  et al,60 Gatha Raoet al61 and Crespo 
Erchigaet al,64 where hypopigmented lesions constituted 83%, 75% and 58% 
respectively of the PV lesions.  Pityriacitrin and similar indole alkaloids produced 
by M. furfur and probably other Malassezia species induces apoptosis of human 
melanocytes and this is one likely explanation for the higher incidence of 
hypopigmented lesions observed in this study.85 
 
 In this study, 28.8 % of patients had pruritus [Table 5].  This is in 
accordance with the study conducted by GathaRaoet al61 in 2002, where 30% of 
the patients had pruritus.  
 
 In the present study, 32.9% of the patients had history of recurrence [Table 
7].  Kristany et al83 observed a 26% recurrence in Indonesian population.  On the 
contrary, Gatha Rao et al61  observed recurrent PV in only 3% of the Indian 
patients. Malassezia species are commensals on healthy skin and tend to become 
pathogenic when host immunity is altered (as in chronic intake of steroids and 
other immunosuppressant drugs, HIV infection, tuberculosis and malignancy) and 
thus infections caused by Malassezia tend to be recurrent. 
 
 In the present study, a positive family history of lesions similar to pityriasis 
versicolor was observed in 27.4% of patients [Table 6].  Faergemann and 
Fredreichson49 in 1979 observed a positive family history in 18% of the PV 
patients, Gatha Rao et al61 observed 38% and Deepak Kumar et al 62 in 2005 
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observed  6% of PV patients with history of similar lesions in other family 
members.  Though a positive family history has been noticed in more cases than 
chance would permit, whether it is genetically determined or due to increased 
exposure of family members to the causative fungal agent, is yet to be 
determined.83 
 
 In this study, majority (54.8%) of the patients with pityriasisversicolor 
presented with moderate amount of scales in the lesions.  28.8% had mild scales 
and 16.4% had severe degree of scaling in the lesions [Table 8].  This is in 
accordance with the studies of Tschen56 in 1984 and Assaf and Weil59 in 1996 
who observed that scales were present in all patients with pityriasis versicolor and 
also with the studies by Gatha Rao et al61 in 2002 and Ghosh et al95 in 2008, 
where 75% and 89% of patients with PV respectively, were found to have 
moderate to severe scales in the lesions. 
 
 In the present study, 38.4% of the patients had excessive sweating, 31.5% 
gave history of using bath oils, 17.8% had history of diabetes mellitus or other 
immunocompromised states like HIV infection, rheumatoid arthritis, post renal 
transplantion status, 9% were on steroids or other immunosuppressive drugs 
[Table 16].  Excessive sweating as a risk factor in the causation of PV was 
statistically insignificant (p value 0.39) in this study.  Gatha Rao et al61  observed 
immunocompromised status like tuberculosis, diabetes mellitus or malignancy in 
18.3% of the patients.  Baillon,57Reed,58 Burke66 and Faergemann47  have found 
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the use of steroids, pregnanacy, poor general health, use of oral contraceptives and 
hyperhidrosis as predisposing factors for pityriasis versicolor. 
 
 The isolation rate of Malassezia species from clinically diagnosed cases of 
pityriasis versicolor was 76.7% in this study[Table 9].  Faergemann et al49 in 
1979 reported a 100% recovery rate, Sidhartha Dutta et al,67 59% in 2002, Kindo 
et al,78 68.75% in 2004 and  Ebrahimzadeh et al,50  81% in 2009.   The differences 
in the isolation rates in various studies may be due to the differences in sampling 
techniques and the use of different media  for culture, like modified Dixon’s 
medium, Leeming and Notman agar and SDA with olive oil.   
 
 In the present study, the duration of lesions in the majority (60.3%) of  PV 
patients was between 1 to 6 months [Table 11].  86.4% of those who presented 
with this duration of lesions were positive by culture.  This correlation between 
the duration of lesions and culture positivity is statistically significant (p value 
0.015).  According to Kristany et al,83 72% of the PV patients presented with 
duration of  lesions in the 1 month – 1year range and 73% of them were culture 
positive.   
 
 In this study, the recovery rate of Malassezia species was more from the 
hyperpigmented type (92.6%) of  PV, compared to the hypopigmented type 
(67.4%) [Table 10].  This correlation was found to be statistically significant (p 
value 0.013).  According to Kristany et al,83 hyperpigmented lesions were found 
in 19% of the study population and all of them were culture positive.  This is 
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explained by the fact that hyperpimented lesions have been found to contain more 
hyphae and spores than the hypopigmented ones.36 
 
 In the present study, the most common species isolated from culture 
positive cases of PV was M. globosa (53.6%) followed by M. sympodialis 
(21.4%) [Table 12].  This is concordant with the studies by Siddhartha Dutta et 
al67 in 2002, Tarazooie et al63 in 2004,  Crespo Erchiga et al 64 in 2000 and 
Thayikannu et al68 in 2013 who observed the most common isolate to be 
M.globosa.  But Gupta et al65 in 2001 and  Kindo et al78  in 2004  reported 
M.sympodialis to be the most common isolate and Makimura et al49 in 2000  
reported M. furfur to be the most common isolate recovered from PV lesions. 
 
 In this study, M. globosa was the most common species isolated from both 
hypopigmented (67.7%) and hyperpigmented (36%) types of PV [Table 14]. It 
was also the most common species isolated from PV lesions on the back (59.4%) 
and face (58.4%) [Table 13].  But this correlation between site of PV lesion and 
Malassezia species isolated was statistically insignificant (p value 0.066).  This is 
in concordance with the studies by Shah et al98 in 2013 and Thayikannu et al,68 
who also reported M. globosa to be the most common isolate obtained from both 
hypopigmented and hyperpigmented types of PV.  The higher esterase activity 
and lipase activity and hence the higher pathogenicity may be the likely cause for 
M. globosa being the most common isolated species.98 
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SEBORRHEIC DERMATITIS: 
 The etiological role of yeasts of the genus Malassezia has been established 
in seborrheic dermatitis, a superficial, flaky dermatoses affecting body sites rich 
in sebaceous glands.   
 
 In this study, people in the 40 – 49 years age group were commonly 
affected with SD (44%), followed by those in 30 – 39 years age group (33%) 
[Table 17].  The median age of occurrence of SD was 38 years.  The median age 
of occurrence was 27.3 years in Iranian population according to Hedayati et al69 in 
2010, and 35 years according to Khosravi et al77 in 2009.  Various studies indicate 
that the colonization pattern of Malassezia species varies in different age 
groups70,71.  Bergbrantet al72 in 1992, also observed that the colony counts are 
generally lower in children and decreases again in elderly individuals.  This 
condition may be related to the differences in sebum secretion in these age groups.   
 
 In the present study, 74% males were found to be affected with SD in 
contrast to 26% of females [Table 17]. This is in accordance with the study by 
Khosravi et al77 in 2009, where 60% of the affected individuals were males.  
Studies by Saghazadeh et al74 in 2010 and Shivprakash et al76 in 2014, observed 
SD to be common in females.  The lesser number of female patients in this study 
may be due to the negligent attitude of women in the lower socioeconomic strata 
towards SD, as it is only a minor cosmetic ailment. 
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 In this study, face (33.3%) and scalp (29.6%) were the common sites 
involved in SD [Table 18].  This is in accordance with the studies by Hedayati et 
al69 and Shivprakash et al76 where scalp was the most common site involved.  
Seborrrheic dermatitis of the scalp (dandruff) being easily noticeable and widely 
publicized by the cosmetic industry, it is relevant that patients with this form of 
SD present more commonly and early to the dermatology clinic.   
 
 52% of those with clinically diagnosed SD were culture positive for 
Malassezia in the present study [Table 20].  In studies by  Kindo et al78 and 
Hedayati et al,69 68% and 77% respectively, of the specimens were culture 
positive.  These differences may be due to the differences in the culture media 
used. Modified Dixon’s agar was used in the above mentioned studies.  
 
 In this study, 66% of SD lesions of 3 months to 1 year duration were 
culture positive and 50% of lesions of more than 1 year duration were culture 
positive [Table 24]. This correlation was not statistically significant (p value 
0.39).  This is in accordance with the study by Khosravi et al83 in Iranian 
population, where 72% of patients with duration of lesions in the 1 month – 1year 
range were culture positive.   
 
 75% of scalp lesions and 60% of lesions on the chest and back were culture 
positive in the present study [Table 21].But the correlation was statistically 
insignificant (p value 0.36).  This is more or less concordant with Hedayati et al69 
who have reported 78% of scalp lesions and 71% of the trunk lesions to be culture 
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positive.  No statistical correlation has been noticed between the lesion site and 
culture result in this study also.  
 
 In the present study, M. globosa (50%) was the most frequently 
encountered species in SD cases, followed by M. furfur (28.6%) [Table 22]. 
Shivprakash et al76 reported that M. globosa and M. restricta were recovered 
commonly form SD lesions in North Indian population and M. globosa, M. 
restricta and M. furfur from South Indian population.  According to Hedayati et 
al,69M. globosa and M. furfur were the most common isolates obtained from SD 
lesions in Iranian patients.  Gaitanis et al79 in 2006 similarly reported M.globosa 
to be the common among Greek SD patients.  Kindo et al78reported M.furfu rto be 
common in SD patients in India.  SD lesions in Swedish patients are more 
frequently found to be colonized with  M.obtusa82. The differences in the isolates 
recovered may be attributed to the geographical differences and sampling and 
culture techniques used.  M. globosa, by virtue of its possessing high lipase and 
esterase enzyme activities has been said to be the most common causative agent.    
 
 In the present study, M. globosa was the most common species isolated 
from the face (50%), scalp (50%) and chest (66.7%) [Table 23]. M. furfur was the 
second most common species from these three sites.  According to Hedayatietal,69 
M.globosa (55.8%) was the most common species isolated from scalp and face 
lesions SD and M. furfur (32.5%)from trunk lesions. This result also agrees with 
the study by Gupta et al70in which contact plate method was used to isolate 
Malassezia species from the various body sites of patients with SD.  The 
95 
 
predominance of M. furfur in the tropics might be due to the presence of 
pityriacitrin, an indole alkaloid84 which has the ability to protect the fungus 
against ultraviolet light, rendering M. furfur more resistant to sun exposure. 
 
 PV and SD lesions in patients with HIV and AIDS have been found to be 
extensive and refractory to standard therapy.27  In this study, 11% of those with 
SD were diabetic, 7.4% were infected with HIV and 3.7% had history of steroid 
intake [Table 25].  In 2006, Rincon et al86 found extensive SD in patients with 
HIV whose CD4 counts were below 500 cells/ cu.mm. 
 
 On analysing the results obtained in PV and SD patients in this study, both 
the conditions were found to be common in males [Tables 2 & 17].  Both the 
conditions were common in young adults, PV being common in 20 – 29 years age 
group [Table 2] and also adolescents, and SD in the adults of 40 – 49 years age 
group [Table 17].  Most of the PV and SD cases presented within 3 months to 6 
months of illness.  33% of the patients had recurrence in both the conditions 
[Tables 7&19].  The common site to be involved in PV was back and that in SD, 
face and scalp [Tables 3&18]. 
 
 Culture positivity for Malassezia spp. was higher in PV (77%) compared to 
SD (52%) [Table 26].  In both the conditions, M. globosa was the most common 
species isolated.  The second most common agent was M. sympodialis in PV and 
M. furfur in SD [Table 27].  A significant number of patients with diabetes 
mellitus, history of steroid intake, HIV infection and other immunocompromised 
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states like rheumatoid arthritis, post-renal transplant state were encountered in 
both the conditions [Tables 16 & 25]. 
 
 
MIC OF THE ISOLATES:  
 The MIC ranges obtained in the present study are comparable to those of 
the studies by Margarita et al,88 Tiwari et al,90 Gupta et al,91 Schmidt et al, 92 
Hammer et al, 93  and Marcon et al.94  The comparisons are tabulated below: 
 
 FLU – fluconazole, KETO – ketoconazole, ITRA – itraconazole,VORI – 
voriconazole, Amp B – Amphotericin B. 
 
Malassezia 
species Study 
FLU 
(μg/ml) 
KETO 
(μg/ml) 
ITRA 
(μg/ml) 
VORI 
(μg/ml) 
AMP B 
(μg/ml) 
M. globosa 
Present study 0.06 – 8 0.06 – 4 0.03 - 4 0.03 - 8 0.03 - 2 
Others88, 91 - 94 0.125 - 16 0.008 – 0.125 0.016 – 8 0.03 - 8 0.06 - 1 
M. 
sympodialis 
Present study 0.06 – 4 0.06 – 0.25 0.03 - 1 0.03 – 0.5 0.06 - 1 
Others88, 91 - 94 0.03 – 4 0.06 – 1 0.06 – 0.5 0.03 -0.5 0.03 - 2 
M. furfur 
Present study 0.06 – 1 0.03 - 2 0.03 – 0.125 0.03 - 1 0.03 - 4 
Others88, 91 - 94 0.25 - 64 0.03 – 0.125 0.03 – 0.5 0.03 – 0.25 0.5 - 8 
M. restricta 
Present study 0.06 – 1 0.06 - 2 0.03 – 4 0.06 - 4 0.03 - 4 
Others88, 91 - 94 0.5 - 4 0.016 – 4 0.016 – 2 0.06 - 8 0.06 - 2 
M. obtusa 
Present study 0.25 - 2 0. 5 0.125 – 1 0.06 – 2 0.06 – 0.5 
Others88, 91 - 94 0.25 - 8 0.06 - 4 0.03 – 0.5 0.03 - 2 0.03 - 8 
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 In the present study, the lowest MIC50 value for M.globosawas observed 
with amphotericin B (0.06μg/ml), for M. sympodialis with itraconazole and 
amphotericin B (0.06μg/ml), for M. furfur with ketoconazole and 
itraconazole(0.125μg/ml), for M. restricta with fluconazole and 
itraconazole(0.06μg/ml), and for M. obtusa with voriconazole and amphotericin B 
(0.06μg/ml).   
 
 Low MIC ranges were noted with ketoconazole and itraconazole, 
indicating high sensitivity of Malassezia species to these azoles.  This is in 
concordance with the studies by Gupta et al, 91 Schmidt et al92  and Hammer et al, 
93  where MIC ranges of ketoconazole were between 0.03 – 2 μg/ml.   
 
 The main purpose of MIC determination is the detection of resistance.  As 
the effect of testing variables on MICs for Malassezia yeasts and their 
reproducibility has not been evaluated as for other yeasts, a reliable comparison of 
MIC data is rendered difficult.   
 
 
 
 
 
 
 
        SUMMARY 
 
 
98 
 
SUMMARY 
 
 This cross sectional study done for a period of one year at a tertiary care 
hospital in Chennai, included a total of 100 patients who were clinically 
diagnosed with either pityriasis versicolor or  seborrheic dermatitis.  The 
epidemiological profile and antifungal susceptibility pattern of the Malassezia 
species isolated from the lesions in study population were analysed and the results  
are summarized below: 
 
 Of the total 100 patiens enrolled in the study, 73 were clinically 
diagnosed to have pityriasis versicolor and the remaining 27, seborrheic 
dermatitis.  The study population consisted of patients belonging to all 
age groups and both sexes.   
 
 Pityriasis versicolor commonly occurred in the 20 – 29 years age group 
(42.5%) and SD in the 40 -49 years age group (44.5%).The median age 
of occurrence was found to be 24 years for PV and 38 years for SD.   
 
 Males were affected more commonly than females in both PV (72.6% 
males) and SD (74% males). 
 
  In both sexes, the 20 – 29 years age group was commonly affected  in 
the case of PV(32.9% of males and 9.6% of females) and the 40 – 49 
years age group in the case of SD (29.6%  males and 14.9% of  females 
belonged to this age group).    
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 Majority of the pityriasis versicolor patients presented with lesions on the 
back (50.7%), followed by face and neck (24.7%).  Face (33.33%) and 
scalp (29.63%) were the common sites involved in SD, followed by chest 
and back (18.52%).   
 
 Pruritus was present in 28.8% of the cases of PV. 
 
 27.4% of those with PV had a family history of similar lesions. 
 
 32.9% of the patients with PV and 33% of the patients with SD had 
recurrent lesions.  SD involving scalp was found to occur recurrently 
compared to lesions on the other sites.   
 
 63.1% of the patients had hypopigmented type (achromic PV) of 
pityriasis versicolor and 36.9% had hyperpigmented (chromic) type.   
 
 Majority (54.8%) of the patients with pityriasis versicolor presented with 
moderate amount of scaling in the lesions.  Severe degree of scaling was 
commonly noticed in the hyperpigmented type of PV.  
 
 The overall isolation rate of Malassezia species was 70% of the total 
study population of 100. 
 
  The isolation rate of Malassezia species was higher from PV lesions 
(76.7% of the 73 PV cases), while it was only 52% from the SD lesions 
(27 SD cases). 
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 Among the PV cases, 92.6% of the hyperpigmented lesions were culture 
positive compared to 67% in the hypopigmented type.  This result was 
statistically significant (p 0.013). 
 
 In SD, 75% of scalp lesions and 60% of lesions on the chest and back 
were culture positive for Malassezia species. 
 
 The duration of lesions in majority of patients with pityriasis versicolor 
was between 1 to 6 months (60.3%).  86.4% of cases with this duration 
of lesions were culture positive for Malassezia.  66% of SD lesions of 3 
months to 1 year were culture positive.  This correlation between the 
duration of lesions and culture positivity was statistically significant      
(p value 0.015) in the case of PV lesions. 
 
 M. globosa was the most common species isolated (53.6%), followed by 
M. sympodialis (21.4%), in PV.  M. globosa was the most frequently 
encountered species (50%) in SD cases, followed by M. furfur (28.6%).   
 
 M. globosa was the most common species isolated form back (59.4%) 
and face (58.4%) lesions of PV and M. sympodialis was the predominant 
species isolated from chest lesions (44.5%).  In SD, M. globosa was the 
most common species isolated from the face (50%), scalp (50%) and 
chest (66.7%).  M. furfur was the second most common species form 
these three sites.   
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 M. globosa was the most common species isolated from both the 
hypopigmented (67.7%) and hyperpigmented (36%) types of PV.   
 
 M. globosa was the most common species isolated from both new 
(39.3%) and recurrent cases (14.2%) of PV and SD.   
 
 Risk factors like excessive sweating, use of bath oils, 
immunocompromised status were present in 38.3%, 31.5% and 12.3% of 
the PV cases respectively.  In the case of SD, 11% of the cases were 
diabetics and 7.4% of them were HIV positive.   
 
 Antifungal susceptibility by broth microdilution method using 
Christensen’s urea broth, was performed for the 70 Malassezia isolates 
using fluconazole, ketoconazole, voriconazole, itraconazole and 
amphotericin B.   
 
 MIC range of Malassezia species were 0.06 – 8 μg/ml for fluconazole, 
0.03 – 4 μg/ml for ketoconazole, itraconazole  and amphotericin B, and 
0.03 – 8 μg/ml for voriconazole. 
 
 Low MIC ranges and MIC50 values were noted with amphotericin B, 
ketoconazole and itraconazole for most of the Malassezia species, 
excepting a few strains of M. globosa and M. restricta. 
 
 
 
 
 
 
CONCLUSION 
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CONCLUSION 
 
 Yeasts of the genus Malassezia are part of commensal flora of human and 
animal skin, which under the influence of various predisposing factors, are 
capable of causing a spectrum of conditions from superficial dermatologic lesions 
causing only cosmetic disfigurement to serious, life threatening systemic 
infections and fungemia.  This study was aimed at analyzing the epidemiological 
attributes and other risk factors involved in the clinical patterns of the common 
superficial infections namely, pityriasis versicolor and seborrheic dermatitis 
caused by Malassezia species in this part of India.   
 
 Adolescents and young adults of both sexes were the ones commonly 
affected with the superficial skin infections analyzed and hence they assume 
cosmetic significance.  Malassezia globosa was the most common species isolated 
from both  hypopigmented and hyperpigmented pityriasis versicolor and also from 
seborrheic dermatitis.  In the case of PV, the isolation rate  of Malassezia species 
was significantly higher from the hypepigmented type, and  also higher in patients 
who presented with PV lesions of  1 to 6 months duration. 
 
 The in vitro antifungal susceptibility testing results were comparable with 
those of previous studies.  However, for Malassezia species, standard testing 
conditions and clinical breakpoints have not yet been established and it remains 
unclear whether the in vitro activity of the antifungal agents tested is predictive of 
clinical outcome.  Hence, routine antifungal susceptibility testing along with 
analysis of clinical outcome should be performed in future studies. 
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 Confirmation of a clinical diagnosis of Malassezia infections by direct 
microscopic examination of the clinical material collected and culture techniques 
is important, as different species are involved in the etiological role in different 
geographical locations and also due to interspecies differences in susceptibility 
patterns to antifungal agents.  As culture forms the basis for species level 
identification through biochemical tests and choosing of an appropriate antifungal 
agent through determination of MIC, the information provided by culture will be 
very valuable in paving way for a tailored clinical approach, thus reducing 
chronicity, recurrences and systemic complications associated with these 
infections and also for a better understanding of the epidemiology of Malassezia 
species.  
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APPENDIX - 1 
LIST OF ABBREVIATIONS USED 
 
AhR                          -         Aryl hydrocarbon Receptor (AhR) 
AIDS   - Acquired immunodeficiency syndrome 
ATCC   - American type culture collection 
CFU   - Colony forming units 
CFW   - Calcoflour White stain 
CLSI   - Clinical Laboratory Standards Institute 
DMSO            - Dimethyl Sulfoxide  
ELISA  - Enzyme Linked Immunosorbent Assay 
FFA   - Free fatty acids  
HIV         - Human Immunodeficiency Virus       
HPE   - Histopathological Examination 
KOH   - Potassium hydroxide 
MIC   - Minimum Inhibitory Concenteration 
PAS   - Periodic Acid Schiff 
PFGE     - Pulsed Field Gel Electrophoresis 
PUVA          -      Psoralen Ultraviolet A 
PV   - PityriasisVersicolor 
RFLP                - Restriction Fragment Length Polymorphism 
RPMI                    - RoseWell Park Memorial Institute                                        
ROS                     - Reactive Oxygen Species 
SDA                   - Sabouraud  Dextrose Agar 
SD                       - Seborrheic Dermatitis 
UV                    - Ultraviolet 
 
APPENDIX  II 
 
MEDIA, STAINS AND REAGENTS 
 
1. 10% KOH with Parker Quink’s blue black ink 
                        Potassium hydroxide                            l0g 
                        Glycerol                                                l0ml                          
  Distilled water                                      80ml 
 10 g of KOH crystals are dissolved in distilled water by stirring slowly and glycerol 
is added.  Parker Quink’s blue black  ink is added to the prepared solution in equal volume 
before use. 
  
2. Gram stain 
             Methyl violet                         l0g Methyl violet in l00ml 
      absolute alcohol in 1litre of 
      distilled water (primary stain) 
  Gram’s Iodine                         l0g Iodine in 20g KI (mordant) 
  Acetone                         Decolourising agent 
  Carbolfuchsin 1%         Secondary stain (counter stain) 
  
3.  Catalase 
  3% hydrogen peroxide 
 
4.  Christensen’s Urease test medium 
  Peptone                                                    1g 
  Sodium chloride                                       5g 
  Dipotassium hydrogen phosphate            2g 
                        Phenol red                                                6ml                          
                        Distilled water                                          1 litre 
                        10% sterile solution of glucose                 l0ml 
                         Sterile 20% urea solution                          l00ml 
 
 Sterilize the glucose and urea solutions by filtration. Prepare the basal medium 
without glucose and urea, adjust to pH 6.8-6.9 and sterilize by autoclaving in a flask at 
121°C for 30min. Cool to about 50°C, add the glucose & urea.   
5.  Sabouraud dextrose agar 
  Dextrose                                                40g 
                        Peptone                                                  l0g 
                        Chloramphenicol                                   500 mg 
  Cycloheximide                                      500 mg 
                        Agar                                                        20g 
                        Distilled water                                        l000ml 
                        p H  = 5.4   
 
 65 g of dehydrated medium  (HiMedia ) should be reconstituted in 1 litre of distilled 
water.  The pH is adjusted to 5.4.  Cycloheximide is dissolved in acetone and 
chloramphenicol is dissolved in 95% alcohol and added to the medium. Sterilize by 
autoclaving at 121ºC for 20 min. 
 
6.Esculin Agar: 
                        Casein enzyme hydrolysate                     13 g 
                        Sodium chloride                                         5 g 
                        Yeast extract                                              5 g 
                        Beef heart infusion                                    2 g 
  Esculin                                                       1 g 
                        Ferric citrate                                            0.5 g 
                        Agar                                                          15 g 
                        Distilled water                                         1000 ml 
                        Final pH                                                   7.3 ± 0.2 
 41.5 g of dehydrated medium (HiMedia) should be reconstituted in 1 litre distilled 
water.  Dissolve by boiling and adjust pH to 7.3.  Dispense in 3 ml quantities in tubes and 
autoclave at 121˚ C for 20 min.  Cool the tubes in a slant position.   
 7.  Tween Compounds:  
Tween compounds are water – soluble, nonionic surfactants, which are polymers of 
ethylene oxide linked to sorbitan and a lipophilic group.   
Tween 20      -      polyoxyethylene (20) sorbitanmonolaureate 
Tween 40       -     polyoxyethylene (20) sorbitanmonopalmitate 
Tween 60        -     polyoxyethylene (20) sorbitanmonostearate 
Tween 80        -     polyoxyethylene (20) sorbitanmonooleate 
Sterilised at 160˚C for 1 hour in hot air oven. 
 
 
 
 
 
 
 
          ANNEXURES 
ANNEXURE 1 - MASTER CHART 
 
  
  
ANNEXURE –2 
PROFORMA 
 
 
 Name :                                                                       OP NO: 
 Age:                                                                           Ward: 
 Sex: 
 Occupation: 
 Address: 
  
 Presenting complaints 
 
 Duration of illness 
 
 History of  
 
 increased sweating 
 use of bath oils 
 prolonged usage of corticosteroids or antibiotics 
 Diabetes mellitus  
 Cushing’s syndrome 
 Acquired Immunodeficiency Syndrome 
 Immunosuppressive therapy 
 Transplantation or malignancy 
 
 Previous history of similar illnes 
 
 Previous Medical History 
 
 Prior antifungal therapy 
 
 Personal history 
 
 Family history of similar illness 
 
Clinical Examination: 
 
 Site of lesion 
 Type of lesion 
 
Hypopigmented or hyperpigmented 
 
Scaling 
 Pruritus 
 
Clinical Diagnosis 
 
Microbiological investigations: 
 Direct examination: 10% KOH mount with Parker Quink’s ink 
 Culture : Fungal growth on 
 
SDA (containing chloramphenicol &actidione) with sterile olive oil overlay 
SDA (containing chloramphenicol &actidione)  without olive oil overlay 
 
 Macroscopic appearance of colony 
 Gram staining 
 Urease test 
 Catalase test 
 Lipid dependance 
 Tween assimilation test 
 Esculin hydrolysis test 
 Growth at 41˚ C 
 Antifungal susceptibility pattern of the  isolate 
 ANNEXURE –3 
CONSENT FORM 
  
STUDY TITLE: Isolation of Malasseziaspecies from patients clinically 
diagnosed with pityriasisversicolor and seborrheic dermatitis and 
determination of antifungal susceptibility of the isolates 
 
I…………………………………………, hereby give consent to participate in 
the study conducted by Dr. Jersey Gayathiri M., Post graduate at Institute of 
Microbiology, Madras Medical College, Chennai and to use my personal 
clinical data and the result of investigations for the purpose of analysis and to 
study the nature of the disease, I also give consent to give my clinical 
Specimen (skin or scalp scrapings) for further investigations. I also learn that 
there is no additional risk in this study. I also give my consent for my 
investigator to publish the data in any forum or journal. 
 
Signature/ Thumb impression                                   Place                                        
of the patient/ relative                                                Date 
Patient Name & Address: 
 
Signature of the investigator: 
MASTER CHART 
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